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ABSTRACT
HSV-1 (KOS)AgK, a virus lacking the UL53 gene coding for glycoprotein K(gK)
was constructed, characterized and compared to the partially deleted gK-null virus
HSV-1 (F)-gKp. AgK and F-gK(J viruses produced microscopic plaques on Vero cells at
48 hours post infection. F-gKp plaques at 72 hours post infection contained fused cells
(syn), while AgK plaques resembled wild-type KOS plaques (syn*). AgK replicated
efficiently in exponentially dividing Vero cells whereas F-gKp yields were 10 and 1000fold lower than AgK yields in HEp-2 or log-phase Vero cells, respectively. Electron
micrographs of AgK-infected Vero cells revealed large numbers of capsids in the nuclei
of Vero, but not HEp-2 cells, while a small number of enveloped virions were observed
in the cytoplasm of infected Vero and HEp-2 cells that failed to translocate to the
extracellular spaces. KOS and AgK replicated inefficiently in gK-transformed cells,
with the exception of VK302 cells. Electron micrographs of the gK-transformed BL-1
cells infected with KOS revealed virions within perinuclear spaces, while there were no
virions visualized in AgK infected BL-1 cells. VK302 cells were the only gKtransformed cells that supported the replication and cellular egress of both KOS and
AgK
To fine-map the functional domains of gK involved in membrane fusion, a longPCR site-directed mutagenesis system was developed that efficiently produced single
base substitutions within larger than 4 kbp DNA fragments. Utilizing this system three
different mutations were engineered and recombinant viruses containing one of the
three mutations were isolated. The mutation at position 31 resulted in a syn* virus.
This research revealed that gK is involved in nudeocapsid envelopment and
cellular egress of infectious virions. Actively replicating cells can partially compensate
for envelopment but not for the cellular egress defidendes of AgK Interference of viral
replication in gK-transformed cells suggests that the cellular gK can function in-trans to
inhibit egress by preventing certain cellular factors required for viral egress to function

x
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efficiently. These results implicate that viral egress involves cellular receptors that are
modified to act as "pilots" or "sorters" for virus transport and egress in a similar
fashion to intracellular glycoprotein transport.

xi

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

CHAPTER I
INTRODUCTION
STATEMENT OF PROBLEM AND HYPOTHESIS
Wild-type HSV-1 infections cause limited amounts of cell fusion that are
characterized by characteristic cyto pathology of round swollen cells in natural
infections and in cell culture (Brown et al., 1973; Hoggan and Roizman, 1959; Person et
a l, 1976; Spear, 1993). Mutant viruses have been occasionally isolated in natural
infections and in cell culture that cause cell fusion or syncytia characterized by
extensive fusion of cells to form multi-nucleated cells. The syncytial mutations that
cause this extensive fusion phenotype were mapped to 5 different loci in the viral
genome. Interestingly, in a majority of the independently isolated syncytial viruses, the
syncytial mutations map to glycoprotein K (gK) that is encoded by the UL53 open
reading frame. Thus, the central hypothesis for these investigations is that gK is a key
regulator of membrane fusion events during virus entry, egress, and virus-induced cell
fusion. Therefore, the absence of gK during viral infection is predicted to cause defects
in virus entry due to defects in virus to cell fusion, virion egress and virus-induced cell
fusion.

RESEARCH OBJECTIVES
The goal of this research was to establish the functional role of HSV-1
glycoprotein K (gK) in the viral replicative cycle, using novel recombination and rapid
site-directed mutagenic methods to engineer deletions and mutations into gK The
specific research aims were:
1.

To determine if gK is essential for HSV-1 virus replication by genetically
constructing a gK-null virus with the entire gK gene deleted.

1

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

2

2.

To examine the phenotypic properties of the gK-null virus, by determining the
plaque morphology, replicative kinetics and plaquing efficiency on different gKtransformed cells.

3.

To compare the genotypic and phenotypic properties of the gK-null virus with
the previously isolated gK mutant virus, F-gK0.

4.

To delineate the functional domains of gK by developing a site-directed
mutagenesis system to obtain mutant viruses with specific amino a d d changes
in the amino-terminal portion of gK

The results from these investigations are presented as three individual chapters
following the literature review and are listed below:
1.

Herpes Simplex Virus Type-1 Glycoprotein K is Not Essential for Infectious
Virus Production in Actively Replicating Cells, but is Required for Translocation
of Infectious Virions from the Cytoplasm to the Extracellular Space.

2.

Viral Interference Mediated by gK-Transformed Cell Lines To HSV-1 (KOS)
Egress and to HSV-1 (AgK) Replication.

3.

Long PCR Site-Directed Mutagenesis of the Amino-Terminal Of HSV-1 gK

LITERATURE REVIEW
Herpesvirus Taxonomy
Herpesviruses are widely distributed in nature infecting most animal spedes.
According to the Herpesvirus Study Group of the International Committee on the
Taxonomy of Viruses, HSV-1 also known as hum an herpesvirus 1 is a member of the
family Herpesviridae, subfamily Alphaherpesvirinae and the genus Simplexvirus (Roizman
et al., 1981). Animal pathogens also induded in this genus are the bovine herpesvirus
type 1 (BHV-1) and bovine herpesvirus type 2 (BHV-2). Other pathogens induded in
the subfamily Alphaherpesoirinae are varicella zoster virus (VZV) the causative agent of
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chicken pox, pseudorabies virus (PrV) which causes Aujeszky's disease in pigs and
equine herpesvirus type 1 (EHV-1) all of which belong to the genus Varicellavirus
(Roizman and Sears, 1996).
All members of the subfamily Alphaherpesvirinae are grouped together on the
basis of certain common characteristics in that they have a broad host range, a
relatively short replicative cycle, spread rapidly in cell culture, efficiently destroy the
cells they infect and possess the capacity to establish latent infections primarily but
not exclusively in the sensory ganglia (Roizman et al., 1981; Roizman and Sears, 1996).

Historical Perspective of Herpesviral Diseases
The word "herpes" has been used as a medical term for at least 25 centimes
(Beswick, 1962). However, it is possible that in ancient times the word was used to
describe conditions as diverse as eczema an d skin cancer. The word "herpes" is
derived from the Greek verb epiceiv meaning to creep, appears to have been used
initially to describe a variety of spreading cutaneous lesions. Eventually, most medical
writers seem to have used the word to describe "zoster", which are the sores that
appear around the waist in the form of a b e lt The belt-like lesions are caused by a
closely related alphaherpesvirus, varicella zoster virus (VZV). The association between
fever and mouth lesions was attributed to Herodotus (Mettler, 1947). William and
Bateman in 1814 first differentiated between labial and genital herpes infections from
herpes zoster (Mettler, 1947). Vidal in 1873 demonstrated that HSV was infectious by
human inoculation experiments (Wildy, 1973). HSV was transmitted to rabbits in 1920
and was shown to be a filterable agent the following year. Andrews and Carmicheal,
(1930) discovered that many adults had circulating neutralizing antibodies to HSV and
that the recurrent herpetic disease occurred only in such individuals. The distinction
between primary and recurrent disease was first elucidated by Burnet and Williams in
1939. In subsequent years, the clinical spectrum of HSV-induced diseases was
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extended to indude eczema herpeticum (Seidenberg, 1941), vulvovaginitis, primary
keratoconjunctivitis (Gallardo, 1943), encephalitis and meningitis (Smith et al., 1941).
Although suggested by Lipschitz in 1921, on clinical grounds it was not until the early
1960s that the existence of two distinct antigenic types, HSV type 1 (HSV-1) and HSV
type 2 (HSV-2), was discovered (Lipschitz, 1921; Nahmais and Dowdle, 1968). A few
years later they observed that the anatomic site of isolation could be correlated
generally to antigenic type.
Herpes simplex viruses (HSV) are common human pathogens associated with a
broad spectrum of illness, ranging from asymptomatic infections to fulminant
disseminated diseases resulting in death. Two speries of Simplexviruses have been
identified, type 1 and type 2 which are very similar in biochemical composition, but
have different biological properties and can be readily distinguished from one another
by a variety of biochemical and immunological techniques. In general HSV-1 causes
orofacial infections, visceral infections in immunocomprimised hosts, and in rare cases
herpes simplex encephalitis. Based on antibody studies, it is estimated that 90% of the
population acquire HSV-1 infections before the ages 4 or 5 years, following which the
virus establishes latency for life in the peripheral ganglia of sensory and autonomic
nerves. Thereafter, recurrent self-limited attacks may occur, provoked by fever, another
viral infection, fatigue, menstruation, and other triggering factors such as UV rays and
wind. HSV-2 is more commonly associated with mucocutaneous infections of the
genital tract, and causes the majority of neonatal diseases. HSV can also infect the
cornea, causing keratitis (Whitley and Gnann, 1993).

Structure of the HSV-1 Virion
The complete virion particle is approximately 120 to 300 nm in diameter
depending on the thickness of the tegument and consists of four structural elements, 1)
a cylindrical core structure around which the viral DNA is wound in the form of a
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torus, 2) a icosahedral capsid which is approximately 100 nm in diameter and 15 nm
thick, 3) a granular zone or tegument which surrounds the capsid, and 4) an envelope,
which is derived from the host cell as the particle buds from the nuclear membrane.
HSV is relatively sensitive to heat and must be stored at -70°C if infectivity must be
maintained for significant periods of time (Roizman and Sears, 1996).
Viral Genome: Like all other herpesviruses, the genome of HSV-1 is a single
linear double-stranded DNA molecule with a molecular mass of approximately 100 X
107 Daltons (Becker et al., 1968; Keiff et al., 1971; Plummer et al., 1969). The genome is
152 kbp with a G+C content of 68% (Becker et al., 1968; Keiff et a l, 1971; McGeoch et
a l, 1988) and exhibits structural properties of a class E herpesviral genome consisting
of two covalently linked components, the Long (L) and the Short (S) regions which
contain unique sequences, thus the name ULand Us- Flanking each of these unique
sequences are the inverted repeat regions (Sheldrick and Berthelot, 1975; Wadsworth et
a l, 1975) (Figure 1.1). During viral replication, the ULand Us segments can invert
relative to one another resulting in four linear isomeric forms (Delius and Clements,
1976; Hayward et al., 1975). Various complementation groups were established using
conditional lethal temperature sensitive its) mutants of HSV-1, in two and three factor
crosses, enabling the functional organization of the viral genome (Schaffer et al., 1974;
Timbury and Calder, 1976). Furthermore, insertional inactivation and deletion of the
various open reading frames indicate that the HSV-1 genome encodes 84 open reading
frames (ORF), of which 60 are located in the ULregion, 14 in the Usregion, 4 in each of
the repeats flanking the ULcomponent and 1 ORF is located in the inverted repeat
bracketing the Us region (McGeoch et al., 1988; McGeoch et al, 1986; Roizman and
Sears, 1996).
Capsid: The capsid is an icosahedral protein shell approximately 15 nm in
thickness and 125 nm in diameter, consisting of 162 morphological subunits or
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capsomeres, 150 of which are the hexons and 12 of which are composed of the pentons
(Wildy and Watson, 1962). Genetic and structural studies have demonstrated that the
assembly of the caps ids is an essential step for virion maturation. HSV-1 infected cell
extracts contain three major types of capsids designated "A" (empty), "B"
(intermediate), and "C" (full), that can be separated by velocity sedimentation through
sucrose gradients (Gibson and Roizman, 1972; Gibson and Roizman, 1974). The "A"
capsids are devoid of DNA and do not contain the internal torroid structure, which is
thought to act as the scaffholding protein for packaging of DNA. The empty "A"
capsids contains four proteins, Viral Protein 5 (VP5)/Infectious cell protein 5
aCP5)(UL19), VP19c (UL38), VP23 (UL18), and VP26 (UL35) (Cohen et al., 1980).
The major capsid protein VP5 accounts for 70% of the capsid mass and forms the
hexons and pentons, VP19c and VP23 together form the trigonal nodules called
triplexes which lie at the capsid floor and connect the capsomeres in groups of three,
and VP26 is found on the distal tips of the hexons. These capsids may be a decay
product not in the pathway of virion maturation. The "B" capsids also lacks DNA but
differ from the "A" type in that the former contains three additional proteins the
VP21/ICP35b, VP22a/ICP35e-f (UL26.5) and VP24, all of which are self-cleavage
products of the UL26 gene product (Lui and Roizman, 1991a; Lui and Roizman,
1991b). Pulse-chase experiments have shown that the "B" capsids are able to package
viral DNA to form "C" capsids, indicating that these "B" capsids may be
intermediates in virus assembly (Perdue et a l, 1976). Type "C" capsids contain the
entire viral genome and a small protein—VP22, in addition to those found in the "B"
capsids (Gibson and Roizman, 1972; Gibson and Roizman, 1974; Rixon et al., 1988).
The "C" capsids are able to mature into infectious virions.
Tegument: The tegument in HSV-1 virions is the amorphous proteinaceous
layer between the underface of the envelope and the outer surface of the capsid and is
usually represented as being variable in size and shape(Roizman and Furlong, 1974).
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Structural proteins that are not part of the capsid or the envelope are generally
assigned to the tegument and their relative amounts are essentially constant for a
particular strain of virus. Certain tegument proteins have the ability to influence the
initiation of infection, notably the alpha-trans inducing factor (a-TTF also known as
ICP25, VP16 or Vmw65, encoded by UL48) which is required for efficient expression
of immediate-early (IE), regulatory or alpha (a) genes (Batterson and Roizman, 1983).
Other components of the tegument include the virion host shutoff protein (VHS,
encoded by UL41), VP1-2 (UL36), VP11-12 (UL46), VP13-14 (UL47) and USll
(Batterson and Roizman, 1983; Chou and Roizman, 1989; Read and Frenkel, 1983;
Roller and Roizman, 1991; Roller and Roizman, 1992; Zhang and McKnight, 1993). The
immediate-early (IE) proteins, ICPO (coded by ccO) and ICP4 (coded by a4) are
important in the transcriptional activation of viral gene expression and have been
reported to be components of the viral tegument (McLauchlan and Rixon, 1992; Yao
and Courtney, 1992). The properties of the virus tegument has been elucidated through
studies on HSV-1 light particles (L-partides) which comprise of enveloped tegument
like structures that lack nudeocapsids (McLauchlan and Rixon, 1992; Sturm et al.,
1987). The absence of capsids from L-partides suggests that the tegument proteins
have the ability to assemble into stable structures without requiring the interaction with
capsids since L-partides were produced under conditions where virion maturation did
not occur (Rixon et al., 1992). However, the processes involved in tegument assembly
and the mechanisms which direct and modulate the amount of each protein
incorporated into virion partides are unknown.
Envelope: The envelope is the outer entity of the HSV-1 virion, acquired as the
virus exits from the nudeus of infected cells and is comprised of the host cell derived
lipid bilayer and viral glycoproteins (Morgan et al., 1959).The presence of lipids was
demonstrated by analysis of virions and their sensitivity to lipid solvents and
detergents (Spear and Roizman, 1972). HSV-1 specifies 17 known or putative
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membrane proteins, 11 of which have been proven to be glycoproteins (gB-UL27, gCUL44, gD-US6, gE-US8, gG-UL4, gH-UL22, gI-US7, gJ-US5, gK-UL53, gL-ULl, gMUL10) (Roizman and Sears, 1996; Spear, 1993). Electron micrographs of thin sections
of HSV-1 infected cells revealed an envelope with a trilaminar appearance, containing
numerous protrusions or spikes (Epstein, 1962). Evidence to date concludes that at
least three virion glycoproteins gB, gC and gD are each present in distinct and different
structures projecting from the virus envelope. There are two kinds of protrusions from
the envelope, rod-like spikes about 14 nm long and short fuzzy material (Stannard et
al., 1987). Colloidal gold coupled directly to monoclonal antibodies to gB and gD has
revealed that the rod-like spikes are composed of gB and the short fuzzy material are
composed of gD. The majority of virion glycoproteins and integral membrane proteins
that have been found in the viral envelope, play important roles in virus attachment,
penetration into cells and translocation of virions to the extracellular space (Roizman
and Sears, 1993).

The Replicative Cycle of HSV-1
The principal events required for HSV-1 infection and replication in cell culture
involves the attachment of the virus to the cell surface, penetration of the virus into the
infected cells, the movement of the capsids to the nucleus where there is a release of
viral DNA, replication of the viral DNA, viral protein synthesis, assembly of capsids,
packaging of viral DNA into the newly formed preassembled capsids and the
maturation of the virus by budding through the inner lamella of the nuclear membrane
(Figure 1.2). Most of the information about HSV viral replication and gene expression
has been obtained in cell culture systems. Characteristic cytopathic changes observed
in HSV infected cells includes ballooning of cells, chromatin condensation and
margination along the nuclear membranes, and intranuclear inclusion bodies (Morgan et
al., 1959).
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Attachment In general, attachment of enveloped viruses can be defined as the
interactions between specific viral envelope proteins and receptors on the target cells.
HSV-1 is a neurotropic virus and in natural infections the virus must replicate in two
types of cells, the epithelial cells at the site of primary infection and the neural cells
where the virus establishes a latent infection; therefore the virus must have receptors on
multiple types of cells. Any constituent of the cell membrane, including carbohydrates,
lipids, and proteins, may act as viral receptors. The cell membrane components serve
normal cellular functions and are subserved by viruses for attachment and entry. The
binding of the virus to its receptor determines in part the viral tropism. Some viruses
have a narrow host range as the binding of the virus to its receptor is with high affinity
and specificity, e.g. HIV binding to the CD4 receptor (McDougal et al., 1986). Whereas,
other viruses have a broad host range and can bind to several molecules on the cell
surface. A number of cellular molecules have been identified as viral receptors, e.g., the
epidermal growth factor receptor for vaccinia virus (Eppstein et al., 1985) complement
receptor type 2 for Epstein Barr virus (Fingeroth et al., 1984), and CD4 for human
immunodeficiency virus (Dalgleish et al., 1984; Klatzmann et al., 1984; McDougal et al.,
1986).
The primary attachment of HSV-1 to cells is through viral protein interactions
with the ubiquitous heparan sulphate moieties of cell surface proteoglycans since HSV1 binding was greatly reduced in cells with altered or depleted cell surface heparan
sulphate proteoglycans (Gruenheid et al., 1993; Shieh et al., 1992; WuDunn and Spear,
1989). Also, heparin, a secretory product similar in structure to heparan sulphate,
inhibits the binding of virus to cells, and virions have been shown to bind to heparinaffinity columns in physiological saline (Mettenleiter et al., 1990; WuDunn and Spear,
1989). Extensive studies have shown that viral glycoprotein, gC facilitates the initial
binding event in polarized cells (Herold et al., 1994; Herold et al., 1991; Spear et al.,
1989; WuDunn and Spear, 1989) as HSV-1 mutant viruses that lack gC are
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significantly unpaired in their ability to bind to cells. Furthermore, HSV-1 gC exhibits
high affinity for heparin under physiological conditions (Herold et ai, 1991) and is a
major viral antigen which elicits a strong neutralizing antibody response, that can block
the binding of the virus to the cells (Fuller and Spear, 1985; Svennerholm et al.t 1991).
In nonpolarized cells, HSV-1 virus devoid of gC attach to cells, suggesting that other
components are involved. HSV-1 glycoprotein B (gB), a second high affinity heparan
sulphate glycoprotein, was found to be involved in binding to cells and may be
responsible for the gC-independent binding (Spear, 1993) (Figure 1.3).
There is growing evidence that the virus uses several receptors on the cell
surface to promote attachment and entry into cells. The basic fibroblast growth factor
receptor (FGFR) was implicated in attachment of HSV-1 in Chinese hamster ovary
(CHO) cells (Kaner, 1991). The CHO cells are normally resistant to HSV-1 infection,
however, when FGFR was expressed in CHO cells they became susceptible to
infection. Spear et al., (1991), could not confirm these results and suggested instead
that the ability of HSV to bind or to penetrate CHO cells was not influenced by the
presence or absence of FGFR. HSV-1 gD has been implicated in binding to cellular
receptor facilitating virus penetration into cells. Brunetti et a i, (1994) identified and
characterized a 275 kDa mannose-6-phosphate/ insulin-like growth factor II receptor,
using soluble forms of gD that were expressed in CHO cells.
Recently, Montgomery et al., (1996) identified a human cDNA from HeLa cells
which transfers susceptibility to HSV-1 entry to normally resistant CHO cells when
stably expressed. The HeLa cDNA codes a 228 amino ad d protein, with
characteristics of a Type 1 membrane glycoprotein. The protein was designated the
herpes virus entry mediator (HVEM) and based on sequence homology and cysteine
repeats in the ectodomain, this protein was included as a new member of Tumor
Necrosis Factor (TNF)/Nerve Growth Factor (NGF) receptor family. HVEM was
shown to enhance entry of a variety of HSV-1 strains in CHO cells.
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HVEM was not involved in virus attachment but was shown to mediate post
attachment entry steps. Thus, heparan sulphate is the principle receptor for virus
attachment and other non-heparan sulphate receptor(s) like HVEM are involved in
post-attachment events including fusion of the virus envelope and release of the
nudeocapsids into the cytoplasm.
Virus Entry: In general, penetration of attached enveloped viruses through the
cell membrane can occur in one of two routes; 1) by direct penetration through the
plasma membrane in a pH-independent pathway or 2) through endocytosis, in a pHdependent pathway. Either of these pathways results in the fusion of the viral
envelope with the cellular plasma membrane or the endosomal membranes. In the pHindependent fusion pathway, the binding of the virus to its receptor induces a
conformational change in the viral envelope glycoproteins as exemplified by HIV-1
binding to the CD4 receptor on the CD4* T-cells. The binding results in molecular
rearrangements in the HIV-1 virion glycoprotein gpl20 and in CD4 which are necessary
to establish an interaction of the fusion domain at the amino terminal of the
transmembrane glycoprotein gp41 with the target cell membrane, thus initiating fusion
(Allan, 1991). In contrast, in the pH-dependent pathway, the virus binding to its
receptor is followed by in te rnalization or endocytosis of virion particles into the
endosomes, and the virion-endosomal fusion occurs within the intracellular veside. The
fusion of the viral envelope with the endosomal membrane is triggered in part by the
effect of endosomal pH changes on the conformation of the viral proteins (Hoekstra
and Kok, 1992; Sturman et a i, 1990). Many enveloped viruses (e.g. the influenza virus,
a orthomyxovirus) and a number of non-enveloped viruses (e.g. poliovirus, a
picomavirus) have been shown to be internalized via endocytosis.
HSV-1, like other herpesviruses, enter cells by fusion of the viral envelope with
the plasma membrane in a pH-independent pathway since low pH and inhibitors that
block endocytosis do not inhibit entry of the virus (Wittels and Spear, 1991).
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Furthermore, fusion of the virus to the plasma membrane can be blocked by
neutralizing antibodies and enhanced by the chemical fusogen polyethylene glycol
which can overcome various kinds of block to infectious HSV penetration (Fuller et al.,
1989; Fuller and Spear, 1985; Fuller and Spear, 1987).
The fusion activity of enveloped viruses to cellular membranes in most of the
different viruses studied to date has a common mechanism, in that a single gene
product confers fusion activity. This mode of mechanism is well-characterized for
influenza virus where the surface protein responsible is the hemagglutinin (HA).
Exposing HA-containing membranes to low pH conditions triggers rapid fusion and in
natural infections this occurs in the endosomes (Stegmann et al., 1989; White, 1992). In
contrast, the mechanism of fusion of the herpesvirus viral envelope with the plasma
membrane is not mediated by any one glycoprotein and no fusion protein has been
identified. The envelope of HSV-1 virion contains at least 11 different glycoproteins,
several of which project as distinct spikes from the membrane surface. Therefore, it
seems possible that binding and the subsequent virus-cell fusion may require a cascade
of multiple HSV-1 specified envelope glycoproteins interacting with several different
sites or receptors on the cell surface. At least four viral glycoproteins, gB, gD, gH and
gL have been shown to be essential for virus entry into cells at a step subsequent to
viral attachment and have all been implicated in the pH-independent fusion of the
viral envelope with plasma membrane (Cai et al., 1988a; Cai et al., 1988b; Ligas and
Johnson, 1988; Roop et al., 1993; Sarmiento et al., 1979; Sarmiento and Spear, 1979). gL
is required for the proper expression and incorporation of gH into virions, but whether
it plays a more specific role in entry has not been determined (Hutchinson et al.,
1992a). The roles of these glycoproteins and the specific events in penetration and
entry is yet to be fully understood. However, deletion mutants of gB, gD, gH and gL
attach to host cells but do not enter (Cai et al., 1988a; Cai et al., 1988b; Desai et al.,
1988; Forrester et al., 1992; Ligas and Johnson, 1988). Also ts mutants with ts lesions in
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the genes that encode gB and gD attach to but fail to penetrate cells (Desai et al., 1988;
Manservigi et al., 1977; Sarmiento et al., 1979; Sarmiento and Spear, 1979).
Furthermore, gD present on the plasma membrane of cells that constitutively express
this glycoprotein interferes with the penetration of superinfecting HSV (CampadelliFiume et al., 1990), suggesting a role for gD in penetration of cells. By direct analysis of
these HSV-1 mutant viruses deleted in the individual glycoproteins and from the entry
kinetic studies, a possible scenario for virus-cell fusion is emerging where the individual
glycoproteins are involved at separate and different points in entry in a sequential
fashion. According to this model, the initial attachment of HSV-1 to the cell surface
heparan sulphate is mediated by gC and or/gB followed by interaction of gD with
cellular receptors in a stable attachment step. The stable interaction is resistant to
heparin washes and is proposed to be a prerequisite for virus fusion with the plasma
membrane (McClain and Fuller, 1994). These interactions triggers fusion between viral
envelope and the plasma membrane and gH is involved in initiation of this fusion
bridge but not in the entry of the nudeocapsid into the cytoplasm (Fuller and Lee,
1992) (Figure 1. 3). Handler et al., (1996) used chemical cross-linking to demonstrate
that the five envelope glycoproteins, gB, gC, gD, gH, gL were dose enough to each other
on the virion envelope where they could be cross-linked into homodimeric and
heterodimeric forms and these together could partidpate in the formation of a fusion
machine as proposed by White, 1992 (Figure 1.3).
Intracellular Transport of Nudeocapsids to the N udeus: Replication of the
viral DNA requires the transport of the nudeocapsid to the nudear pore, where the
viral genome is released from the capsid into the nudeoplasm. The cytosolic transport
of capsids has been reported to be mediated by cellular cytoskeletal microtubules
(Dales and Chardonnet, 1973; Kristensson et al., 1986). Recently, Sodeik et al., (1996)
used microtubule depolymerizing agents in conjunction with immunofluroscence and
immunoelectron microscopy and proposed that the nudeocapsids use dynenin, a
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minus-end directed microtubule dependent motor, to move along the microtubules
towards the centriole from where they are transported to the nudeopore (Figure 1.3).
Cascade Synthesis of Viral Proteins and T heir Coordinated Regulation: The
HSV-1 lytic replication cycle has been described as a coordinated process that involves
the sequential transcription and temporal regulation of at least three viral gene classes:
aplha (a) or immediate early (IE), beta ((1) or early, gamma (y) or late. Early studies
defined the time of appearance and thus the kinetic classification of infected cell
proteins (ICP) on the basis of requirements for either de novo proteins or DNA
synthesis (Honess and Roizman, 1974; Honess and Roizman, 1975). Five a genes,
ICPO, ICP4, ICP22, ICP27 and ICP47, have been identified that are expressed in cells
soon after infection. The transcription of these a genes does not require prior viral
protein synthesis occurring before viral DNA replication. However, the transcription of
these a genes are stimulated by a protein component of the virus particle, ICP25 (also
called a gene frans-indudng factor, a-TIF, Vmw65 or VP16). During productive
infection, the a-TIF forms a complex with the cellular transcription factor Oct-1 and at
least one additional cellular protein resulting in interaction with the octamer binding
sites present in the promoters of the a genes. Two of the five a genes, ICP4 and ICP27
are essential for viral replication in cell culture (Dixon et al., 1983; Sacks et al., 1985).
The accumulation of functional a gene products activates the P genes, many of which
are enzymes involved in nucleotide metabolism and DNA replication, resulting viral
DNA synthesis begins shortly after their expression. The process leads in turn to the
activation of the y genes, which can be further designated into the y 1 and y 2 kinetic
class of genes. The expression of y 1 genes is enhanced by viral DNA, but significant y
1 gene expression can occur prior to, or in the absence of viral DNA replication.
Finally the y 2 genes are transcribed, whose expression is stringently dependent on
onset of virus DNA replication. Many of the HSV y gene products are structural
components of the mature virus particles and are transcribed at early as well as at late

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

18

times after infection. The sequential and regulated pattern of HSV protein synthesis is
influenced at both the transcriptional and post-transcriptional levels (Roizman and
Sears, 1996).
Viral DNA Replication: Upon entry into the nucleus the linear double stranded
DNA genome circularizes and only a small portion of the viral DNA that enters the cell
undergoes replication. Comparison of the terminal structures of mature DNA and the L
and S junction sequences suggests that the circularization of the double stranded linear
DNA molecule takes place by direct ligation of the ends which was observed by
analyzing replication intermediates and from electron microscopic examination of viral
DNA isolated from infected cells (Davison and Wilkie, 1981; Mocarski and Roizman,
1982). Subsequent replication of the circularized DNA yields large head-to tail
concatemers consisting of tandem repeats of the viral genome. Available data suggest
that HSV-1 DNA replicates through rolling circle mechanisms (Becker et al., 1978; Jacob
et al., 1979). However, the simple rolling circle mechanism does not account for
intermediate branched structures or the rapid amplification of viral DNA seen in the
initial hours after infection (Hammerschmidt and Sugden, 1990). Therefore there are
several additional models proposed for the generation of concatermers. Martinez et al.,
(1996) eluded to a DNA replication model, where the initial rounds of replication
occurs by theta (6) replication that is initiated at one or more of the origins of
replication and at late times of infection the rolling circle mode of replication takes
over, generating the head-to-tail concatermers. Another interpretation of this model is
that the initial theta-type replication could be followed by a recombination event where
an inversion occurs between the replicated copy of an inverted repeat unit and an
unreplicated copy, resulting in two replicating forks being developed that generates the
concatemers. A third model proposed for replication is similar to that seen in T4
phages where strand invasion provides the 3' hydroxyl primers for initiation of DNA
replication which can be converted to the replication forks necessary for the generation
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of the concatemers which the mature into unit-length molecules by site-specific cleavage
(Martinez et al., 1996).
The HSV-1 genome contains three cis acting origins (oil) of DNA replication and
genome replication may originate in either direction from any of three origins of
replication (Friedman and Becker, 1977; Hirsch et al., 1977; Stow, 1982; Stow and
McMongale, 1983; Weller et al., 1985). One of the origins, orit maps to the middle of
the L component, between the promoters of the f) genes specifying the major DNA
binding protein ICP8 and the DNA polymerase (Weller et al., 1985). The ot^ consists
of an 144 bp, A+T rich, palindromic region that is unstable when cloned into E.coli. The
other two origins, orisl and oris2 that map to th e 'd sequences flanking the S
component of the genome, between the promoter elements of the a genes, ICP4 and
ICP22 (orisl) (Locker et al., 1982; Weller et al., 1985) or between the a genes ICP4 and
ICP47 (oris2) (Barnett et al., 1983; Deb and Doelberg, 1988; Mocarski and Roizman,
1982; Stow, 1982; Stow and McMongale, 1983). Cell culture studies have
demonstrated that the oriLand at least one of the oris can be deleted (Longnecker and
Roizman, 1986; Polvino-Bodnar et al., 1987) or both oris sequences can be deleted
without affecting viral replication (Igarashi et al., 1993). The strategic location of the
three origins of DNA replication between the transcription initiation sites in the HSV
genome may be regulated by local changes that occur due to the initiation of
transcription in this region (Hubenthal-Voss et al., 1987).
Also aiding in the replication process are seven virus specified proteins that are
essential and sufficient for HSV-1 origin-dependent plasmid amplification in a
transient transfection assay (Wu et a i, 1988). The seven essential viral DNA
replication genes are the UL5, UL8, UL9, UL29, UL30, UL42 and UL52. Briefly, the
UL9 gene product binds specific sequences within the origins of replication of HSV-1
(Elias and Lehman, 1988; Elias et al., 1986) and also possesses helicase activity
(Bruckner et al., 1991; Fiererand Challberg, 1992). UL29 encodes ICP8, a single
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stranded DNA binding protein (Quinlan and Knipe, 1983). The UL30 and UL42 gene
products compose a heterodimeric DNA polymerase in which UL30 codes the
catalytic subunit and UL42 encodes the subunit that acts to increase the processivity
of the enzyme (Chartrand et ai, 1980; Coen et al., 1984; Hay and Subak-Sharpe, 1976;
Honess et d ., 1984; Keir, 1968; Keir and Gold, 1963; Powell and Purifoy, 1977). The
HSV-1 DNA polymerase is unusual in that it is sensitive to compounds such as
phosphonoacetate, phosphonoformate and nucleoside analogs like acydoguanosine.
Finally, the UL5, UL8 and UL52 gene products form a heterotrimeric complex in which
each protein is present in equimolar ratios and function with both 5' and 3' helicase
and primase activities (Crute and Lehman, 1991; Crute et d ., 1989). The seven
replication proteins localize to gobular nuclear structures termed the replication
compartments which are found adjacent to NDlOs, nuclear domains present in all cell
types whose function is unknown (Maul et al., 1996). These central nudear structures
have been defined by the presence of the single-stranded DNA binding protein, ICP8
(de Bruyn Kops and Knipe, 1994).
In addition, the HSV-1 genome codes for a number of proteins involved in
nucleic add metabolism that play important roles in processing, deavage, and
packaging of the genomic viral DNA. Most of these proteins are not essential for viral
replication in cell culture. Some of these virally encoded nudeic add metabolism
proteins are the alkaline nuclease, thymidine kinase, ribonudeotide reductase, uracil
DNA glycosylase and the dUTPase reductase (Roizman and Sears, 1996).
The alkaline nudease is a phosphoprotein which has DNAse activity and is
encoded by the UL12 ORF (Keir and Gold, 1963; McGeoch et d., 1988). Through the
study of ts mutants, the DNase activity of this enzyme was demonstrated to be
essential for viral growth (Francke et d ., 1978). Shao et d ., 1993 reported that HSV-1
m utant viruses that lack the alkaline nudease gene may be defective in genome
maturation and for the production of competent "C" capsids and thus the capsids
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accumulate in the nucleus. Available data indicate that nonlinear branched viral DNA
replication structures arise in cells infected with either wild-type virus or with the
alkaline nuclease-null mutant viruses and that the alkaline nuclease enzyme was
required for the efficient processing of complex nonlinear viral DNA replication
intermediates that arise during replication in these viruses (Martinez et al., 1996).
The viral thymidine kinase (TK) encoded by the UL23 ORF was found to be
essential for viral replication in natural infections, but is dispensable in cell culture. The
TK has been designated as a deoxypyrimidine kinase, though it functions to
phosphoryiate purine pentosides and a wide variety of nucleoside analogs. The unique
property of the viral TK along with its broad substrate range is the basis of antiviral
treatments such as acyclovir and gangicydovir (Roizman and Sears, 1996).
HSV-1 ribonudeotide reductase is a complex enzyme made up of a large and
small subunit encoded by the UL39-ICP6 and UL40 ORFs, respectively (Bacchetti et
a l, 1986; Frame et al., 1986; Huang et al., 1988). The enzyme generates a pool of
substrates for DNA synthesis by reducing ribonudeotides to deoxyribonudeotides
(Roizman and Sears, 1996). The activity of this enzyme is dispensable for viral
replication in actively dividing cells maintained at 37°C but is essential in non-dividing
or stationary phase cells maintained at 39.5°C, indicating to a cellular homolog that
can complement the viral function in actively dividing cells (Goldstein and Weller,
1988).
The viral uracil DNA glycosylase encoded by the UL2 ORF was described by
Caradonna and Cheng (1981), and it has since been shown to be highly conserved in all
other herpesviruses (Cardonna et al., 1987; McGeoch et al., 1988; Wohlrab and Francke,
1980; Worrad and Cardonna, 1988). TheDNA repair and proof reading enzyme
excises uracil residues in DNA that result from the misincorporation of dUTP or
spontaneous deamination of cystosine. The UL50 ORF encodes the HSV-1
deoxyuridine triphosphate nucleotidohydrolase (dUTPase), an enzyme catalyzing the
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hydrolysis of deoxyuridine triphosphate (dUTP) to deoxyuridine monophosphate
(dUMP) which is eventually converted to deoxythymidine monophosphate (dTMP) via
methylation of dUMP by thymidylate synthetase, thus providing a pool of nucleotide
substrates that are incorporated into the newly synthesized viral DNA (Caradonna
and Cheng, 1981). Also dUTPase maintains the low intracellular concentrations of
dUTP so that uracil cannot be incorporated into the newly synthesized DNA.
Assembly of Capsids: Assembly of HSV-1 capsids involves capsid formation,
DNA encapsidation and packaging. Capsid assembly occurs exclusively in the nuclei
of infected cells (Darlington and Moss, 1968; Schwartz and Roizman, 1969). Genetic
and biochemical studies suggest that the HSV-1 capsids are made up of seven
polypeptides, which are encoded from six viral genes. VP5, VP19c, VP22a, VP23,
VP24, and VP26 are the products of the UL19, UL38, UL26.5, UL18, UL26, and
UL35, respectively. Cell and virus-free assembly assays have demonstrated that only
six of the capsid proteins, namely, VP5, VP19c, VP21, VP22a, VP23, and VP24, are
required for proper icosahedral capsid assembly, suggesting that no additional viral
genes are required (Newcomb et al., 1994; Thomsen et al., 1995; Thomsen et al., 1994).
Recently, capsid assembly in the nucleus was reported to occur in distinct "dense
nuclear structures" designated as "assemblons" which are distinct from the viral DNA
replication centers. Immuno-confocal microscopy revealed that assemblons localized to
the periphery of the nucleus and contained the capsid proteins and the newly
discovered capsid assembly accessory protein, the UL43.5 gene product (Ward et al.,
1996). The steps which precede capsid assembly are not fully understood, however,
chemical-cross linking studies reveal that protein-protein interactions play a critical
role in this assembly (Hong et al., 1996; Thomsen et al., 1995). Capsid assembly is
considered to begin when the capsid proteins are transported to the nucleus. The
efficient localization of VP5 to the nucleus depends on its interaction with VP22a, the
scaffolding protein specified by the UL26.5 (Matusick-Kumar et al., 1994; Nicholson et
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al., 1994). After transport to the nucleus, the VP5/VP22a complexes come together by
virtue of the ability of VP22a to interact with itself, forming a structure to which the
other capsid proteins attach to form a large cored "B" capsid (Thomsen et al., 1995).
Using three-dimensional cryoelectron microscopic reconstruction, Newcomb et al.,
1996, showed that capsid assembly begins with a partial capsid and proceeds through
a closed, spherical, procapsid intermediate to the closed, stable icosahedral form seen
in the mature "C" capsid. Three types of capsids "A", "B", and "C" capsids are
produced in HSV-1 infected cells (described in virion structure), which differ from each
other in their capsid protein composition and their ability to package DNA Studies
with ts mutants have identified eight HSV-1 genes UL6, UL15, UL25, UL28, UL32,
UL33, UL36 and UL37 whose products are the non-capsid, accessory proteins
required for the assembly of the DNA containing "C" capsids (Roizman and Sears,
1996). These gene products have been implicated in the various processes involved in
the cleavage and packaging of viral DNA.
Concurrent or following viral DNA replication large DNA concatemers are
synthesized and cut into unit length virion DNA at specific recognition sequences, and
packaged into the preassembled "B" capsids, with the concomitant loss of the
scaffolding protein, VP22a. Cleavage and packaging are tightly linked processes
(Ladin et al., 1980; Sherman et al., 1992). The inverted repeats, ab and a'b' present at
the terminals of the ULand the inverted repeats a'c7and ca of the Us segments of the
viral genome have a variable number of "a" sequences repeats. These "a" sequences
contain two highly conserved sequence elements termed pacl and pac 2 that are the
signals that direct site-specific cleavage for encapsidation of the progeny viral
genomes. Furthermore, the "a" sequences are flanked by direct repeats of a twenty
nucleotide sequence termed direct repeat 1 (DR1) and is composed of two unique
sequences the Uband Uc that are separated by internal repeated arrays that vary in
copy number and sequence between the HSV-1 isolates (Davison and Wilkie, 1981;
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Mocarski and Roizman, 1981; Varmuza and Smiley, 1985). The "a" sequences serves
as the recognition sequence for the machinery that processes the concatemers to unit
length DNA. The cleavage-packaging reaction involves two site-specific breaks that are
made on either side of the "a" sequences, at defined distances from the signals located
in the Ub and Ueregions (Varmuza and Smiley, 1985). Two models for viral
encapsidation were put forward by (Deiss et al., 1986), from the analysis of amplicons.
In the first model, the cleavage-packaging proteins attaches to the Uesequences on the
concatemeric DNA, initiates the first break and scans the viral genome across the UL
towards the Us component until it reaches the Ub sequence and the second cleavage
occurs. Alternatively, the cleavage-packaging complex attaches to the Ue regions of the
"a" sequences scans the genome till it encounters the next Ue-Ub- At this point there is
a duplication of the "a" sequences by a process of gene conversion, following which the
final cleavage occurs in the DR1 of two adjacent "a" sequences (Roizman and Sears,
1996).
Maturation of Virion Particles: The final step in the replicative cycle of HSV-1
is the process of virus maturation, or budding, or egress whereby the newly assembled
capsids acquire the tegument, the bilayer lipid envelope and are transported to the
extracellular spaces. The production of infectious particles is critically dependent on
two steps: first, capsid proteins must selectively encapsidate the viral genome from a
pool of other viral and cellular nucleic adds, and second the capsid must be enveloped
by a membrane containing the viral envelope proteins. Defects in certain tegument
proteins like the UL48 gene product, the a-TIF and the UL11 gene product (encodes a
myristilated tegument protein located on the underside of the viral envelope) also
inhibit viral egress (Ace et al., 1988; Baines and Roizman, 1992; Weinheimer et ai,
1992). Another, tegument protein, ICP34.5, has also been implicated in viral egress, as
null mutants lacking this protein are retained in the perinudear nudear space of
infected cells. In addition, the ICP34.5-null mutants in strain HSV-1 (17) replicate as
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well as the parental wild-type HSV-1 (17) virus in actively dividing cells, whereas in
stationary phase cells the mutant has a defect in viral maturation (Brown et al., 1994).
Deletion mutants in other tegument proteins such as, the products of the UL41, UL47,
US9 genes do not severely affect viral maturation (Fenwick and Everett, 1990; Post
and Roizman, 1981; Zhang et a i, 1991).
The envelopment of HSV occurs as the nudeocapsid transits through the
nudeus acquiring the envelope from the inner nudear membrane (Nii et al., 1968;
Roizman and Furlong, 1974). The exact mechanism by which the assembled capsid
triggers the acquisition of the tegument and envelope is unknown; however, budding
has been observed at specialized patches at the inner lamella of the nudear membrane
(Roizman and Furlong, 1974). The path the virions follow thereof, as they traverse the
cytoplasm to the extracellular space is poorly understood. Based on the immunoelectron microscopic examination of static thin sections of virus infected cells,
immunofluorescence, subcellular fractionation and by studying the genetic and
biochemical aspects of viral glycoprotein transport, two models of viral egress have
been proposed (Figure 1.4).
The first and more widely accepted model (Figure 1.4, model B) suggests that
virions use the cellular secretory pathway being transported within vacuoles or
vesides, derived from the outer lamella of the nudear membrane or the endoplasmic
reticulum (ER), which then fuse sequentially with the Golgi dstemae or with Golgi
derived membranes carrying Golgi enzymes, eventually reaching the plasma membrane
where they are released. The model comes from observations of infectious, enveloped,
extracellular HSV-1 virions with glycoproteins on their surface which have complex Nor Olinked oligosaccharides indicative of Golgi processing. However, the glycoproteins
found on the surface of the nudear membranes are of the immature forms.
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Little is known about whether these mature glycoproteins are added at the time
of initial envelopment and undergo subsequent Golgi level processing during virus
egress or how cytoplasmic enveloped virus transits through the plasma membrane.
Evidence to support the model comes from studies where monensin, an ionophore, that
hinders full processing of glycans, reduces the egress of HSV-1 (Johnson and Spear,
1982). Also, ammonium chloride inhibits the accumulation of mature glycoproteins
although, the synthesis of precursor glycoproteins were unaffected (Kousoulas et al.,
1982). Furthermore, high yields of infectious virions accumulate in the cytoplasm of cell
lines defective in the processing of high mannose to mature glycoproteins (Banfield and
Tufaro, 1990; Campadelli-Fiume et al., 1982). The study of various mutant HSV-1
viruses with mutations or deletions in many viral specified glycoproteins and
membrane proteins revealed 1) Temperature-sensitive(fs) gH mutants accumulate in the
cytoplasm of infected cells, however, virions that do get released to the extracellular
space, lack gH and are thus non-infectious (Desai et al., 1988). 2) Viruses with mutant
gD successfully infect cells that express wild-type gD , however, there was an
accumulation of unenveloped capsids in the cytoplasm, suggesting that in these cells
the virion envelope fused with the cytoplasmic membranes (Campadelli-Fiume et al,
1991). 3) Mutant viruses with deletions in the membrane protein specified by the UL20
ORF accumulate in the perinuclear spaces of infected cells, such as Vero and HEp-2
cells, however, in human 143 TK- cells this defect was compensated (Baines et al.,
1991). Interestingly, Vero and HEp-2 cells upon infection with wild-type virus results
in the fragmentation and dispersal of the Golgi apparatus, without any detrimental
effect on the production of infectious viral particles (Campadelli et al., 1993). Thus, the
UL20 protein was shown to be essential for viral egress in these cells (Avitabile et al.,
1994). 4) HSV-1 mutants lacking glycoproteins E (gE), or glycoprotein I (gl), form small
plaques in human fibroblasts and these glycoproteins in wild-type infections have been
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implicated to play a pivotal role in the basolateral cell-to-cell spread of the virus
(Balan et al., 1994; Dingwell et al., 1994).
The second model (Figure 1.4, model A) originally proposed by Stackpole,
(1969), suggested a pathway where the virus gets enveloped at the inner nuclear
lamella, traverses the perinuclear space and the envelope fuses with the outer nuclear
lamella, releasing the nudeocapsid into the cytoplasm (Figure 1.4). The process is
followed by a second re-envelopment at the endoplasmic reticulum (ER) and/or the
Golgi and the final release into the extracellular space by the fusion of enveloped virion
carrying vesides with the plasma membrane. The major lines of evidence to support
this model show: 1) The examination of confocal and electron micrographs of axonal
transport of virions in the neurons revealed the presence of nudeocapsids in the
cytoplasm (Penfold et al., 1994). The authors implicated that the glycoproteins and
unenveloped nudeocapsids are transported through separate pathways, the
glycoproteins using the neuritic transport vesides while the nudeocapsids utilized the
axonal anterograde micro tubular transport, respectively (Penfold et al., 1994). 2)
Studies with recombinant gH viruses with specific endoplasmic reticulum retention
signals (KKXX) in gH, localized gH and gL to the inner nudear membranes of infected
cells, while the transport of all other glycoproteins were not affected. Also, the
infectivity of the recombinant virus was reduced by 100-fold when compared to the
wild-type virus, however, the number of virion partides present in the extracellular
fluids were similar to that of wild-type (Browne et al., 1996). The consequence of
retaining gH in the ER showed that the progeny virus acquired their envelopes at
another subcellular compartment (Le. at the Golgi or a post-Golgi compartment),
because the secreted virions did not contain detectable levels of gH and were noninfectious. By targeting gH to the Golgi compartments, the virion infectivity was
restored suggesting that the excreted virions incorporated gH (Browne et al., 1996). 3)
Previous reports of maturation and egress of virus in other alphaherpesviruses
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systems, like pseudorabies virus (PrV) and varicella zoster virus (VZV), indicate that
these viruses acquire their final envelope from the frans-Golgi network and their
envelope glycoproteins are transported to the fnzns-Golgj network independently of the
nudeocapsids (Zhu et al., 1995).
Regardless of which pathway the nudeocapsids take as they traverse the
cytoplasm, it is certain that intracellular virion particle transport is regulated by a
number of different proteins and other factors of cellular and viral origins.

HSV-1 Specified Glycoproteins and Membrane Proteins
The HSV-1 genome specifies at least 17 putative membrane proteins that are
either integral membrane proteins or proteins associated with cellular membranes.
These are the ULl-gL, ULlO-gM, UL11, UL20, UL22-gH, UL24, UL27-gB, UL34,
UL43, UL44-gC, UL53-gK, US4-gG, US5-gJ, US6-gD, US7-gI, US8-gE (Spear, 1993;
Roizman and Sears, 1996). Presently, eleven of these proteins have been identified as
glycoproteins which are encoded by ORFs in the UL(ULl-gL, ULlO-gM, UL22-gH,
UL27-gB, UL44-gC and UL53-gK) and Us (US4-gG, US5-gJ, US6-gD, US7-gI, US8-gE)
segments of the viral genome (Figure 1.1). Initially, the major glycoproteins were
designated according to their mobility on SDS-polyacrylamide gels (PAGE) as VP8,
VP7, VP8.5, VP18-19 (Heine et al., 1974; Spear and Roizman, 1972) however, they
were renamed as gB, gC, gD and gE based on their antigenic differences from studies
with polyvalent sera (Baucke and Spear, 1979; Spear, 1976). Most of the glycoproteins
belong to either the ^ or the y kinetic class of proteins and are regulated as such. The
glycoproteins, gB, gC, gD, gE, gG, gH, gL gj, and gK, share some common characteristics
in that they all have 1) a deavable signal sequence at the amino-terminal of the protein;
2) possess membrane spanning hydrophobic domains near their carboxy-termini; and
3) they all contain sites for N-linked glycosylation.
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Some of these glycoproteins, gC, gE, gG, gl, gj and gM are nonessential and are
dispensable for virus infection and replication in most cells in culture as mutant viruses
lacking these glycoproteins showed no discernible phenotypic abnormalities when
compared to the wild-type strains (Balan et al., 1994). gC encoded by UL44, though
not essential for virus production in cell culture (Ryechan et al., 1979), mediates the
initial attachment of HSV-1 virions to the cells by binding to the heparan sulphate
moieties on the cell surface (Fries et al., 1986; Herold et al., 1991; Langeland and
Moore, 1990). gC serves multiple accessory functions including its ability to function as
a receptor for the complement component, C3b (Friedman et al., 1984). gC is also a
major viral antigen which elicits a strong humoral and cellular immune response and
thus protects HSV-1 infected cells from lysis by antibody plus complement; however,
the most important protection is against lysis mediated by complement alone (Fries et
a i, 1986; Harris et al., 1990). Glycoproteins gE and gl, encoded by the US8 and 1)57,
respectively, are involved in the basolateral spread through the junctions of cultured
polarized cells and the complex of gE and gl acts as a receptor for immunoglobulin G
(IgG) (Centifanto-Fitzgerald et al., 1982; Dingwell et al., 1994). The function of gG
specified by the US4 ORF is ill-defined. gG is found in the virion envelope and mutants
lacking this glycoprotein have reduced virulence in experimental animals, but the
mechanism involved is unclear (Balan et al., 1994; Longnecker et al., 1987; Longnecker
and Roizman, 1987; Weber et al., 1987). The US5 ORF was first identified by McGeoch
et al, (1986) who noted the predicted translation product contained a potential Nterminal signal, a transmembrane domain and a single N-glycosylation site. The gene
product was designated as gj; however, no function has yet been assigned to this
putative protein (Roizman and Sears, 1996). The product of the UL10 ORF is gM, a
glycoprotein present in the virions and found associated with the plasma membranes
of infected cells. The protein has the characteristics of a glycoprotein containing the
required N-glycosylation sites and the transmembrane regions; however, the protein
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lacks a deavable signal sequence (Baines and Roizman, 1993). The dispensable viral
structural components, gC, gE, gl, gG, gj and gM play important roles in vivo in
infection of diverse cell types, movement of virus through tissue, or protection from
host immune responses (Balan et al.f 1994; Roizman and Sears, 1996).
gB, gD, gH, gK and gL are glycoproteins essential for virion infectivity. gB, gD
and gH-gL are required for viral attachment and entry (Cai et al., 1988a; Cai et al.,
1988b; Campadelli-Fiume et al., 1990; Forrester et a l, 1992; Hutchinson and Johnson,
1995; Ligas and Johnson, 1988; Roizman and Sears, 1996; Roop et al., 1993; Spear,
1993). The UL27 ORF codes for gB which is one of the most abundantly expressed
glycoprotein component of the virion envelope. The fully glycosylated form of gB is a
homodimer and is one of the most highly conserved glycoproteins among the different
members of the herpesvirus family (Pereira, 1994). Analysis of ts mutants, antibody
resistant mutants and gB null mutants demonstrated that gB is essential for virus
penetration (Cai et al., 1987; Cai et al., 1988b; DeLuca et al., 1982; Highlander et al.,
1989; Little et al., 1981; Sarmiento and Spear, 1979) and certain mutations in gB
compromise the intercellular spread of the virus. Furthermore, point mutations in the
carboxy terminal of gB cause extensive syncytia in cell culture (Bzik et al., 1984a; Bzik
et al., 1984b; Cai et al., 1988b). gD encoded by US6 ORF is involved with interaction
with cellular receptors and is essential for viral entry (Ligas and Johnson, 1988), and
has been implicated in cell fusion (Spear, 1993), superinfection restriction (Johnson and
Spear, 1989), and neuroinvasiveness (Izumi and Stevens, 1990). Purified gD elicits a
neutralizing antibody response and a protective immune response to lethal challenge
with virus. This property of gD has lead to development of hum an subunit vaccines
(Langenberg et al., 1995). The UL44 ORF encodes the glycoprotein H (gH) that can be
detected in HSV-1 infected cells and in purified virions (Buckmaster et al., 1984) and
like gB is ubiquitous among herpesviruses (McGeoch et al., 1986). gH is essential for
viral penetration into cells at a step subsequent to viral attachment (Fuller et al., 1989).

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

32

Mutant viruses devoid of gH are noninfectious, and cells pre-adsorbed with gH-null
virions are resistant to superinfection with wild-type virus, indicating that gH is
required for membrane fusion but not for receptor binding (Forrester et d ., 1992).
Monoclonal antibodies to gH neutralize virus infectivity and inhibit cell fusion by
syncytial viruses (Buckmaster et d ., 1984; Gompels and Minson, 1986). Furthermore,
modifications in the cytoplasmic tail of gH abolishes fusion caused by syncytial strains
(Wilson et al., 1994). Also, gH has been implicated in viral egress as certain ts mutants
with mutations in gH accumulate in the cytoplasm of infected cells, however, virions
that are excreted to the extracellular space are devoid of gH and are thus non
infectious (Desai et al., 1988). Transient expression of gH in COS cells reveal the
intracellular retention, and the presence of precursor carbohydrates, suggesting that gH
may interact with another protein during maturation (Roberts et d ., 1991). A new
glycoprotein L (gL) specified by UL1 has been characterized using antipeptide sera
(Hutchinson et d ., 1992a). gL when expressed, behaves similar to gH, in that the
protein is not properly processed and expressed in the absence of other HSV-1
specified proteins. However, co-expression of both gL and gH enabled both proteins to
be processed and transported to the cell surface, indicating direct interaction of these
proteins in a gH-gL complex that is present in the virion envelope and the plasma
membrane of infected cells, and enables the virus in entry (Hutchinson et al., 1992a).
(Glycoprotein K encoded by the UL53 ORF will be reviewed later). Most of the
glycoproteins of HSV-1 play important roles in pathogenicity, mediating both entry of
the virion into host cells, via attachment and penetration and cell-to cell spread of
virus.
Based on sequence data, the other predicted intrinsic membrane proteins
specified by the HSV-1 genome are gene products of the UL20, UL24, UL34, UL43
and UL45 ORFs (McGeoch et al., 1988; Spear, 1993). The UL20 encodes a membrane
protein, associated with purified virions, the nuclear membranes and with the
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cytoplasm of infected cells (Baines et al., 1991; W ard et al., 1994). The UL20 gene
product plays a vital role in translocation of the enveloped virions from the perinuclear
space to the cytoplasm in Vero and HEp-2 cells. However, deletion of this gene from
HSV-1 causes the mutant virus to cause cell fusion in certain other cell lines such as
143TK cells (Baines et al., 1991). Little is known about the function of the UL24 and
UL43 gene products except that they are dispensable for viral replication in some cells
in culture (MacLean et al., 1991). Mutations and deletions in UL24 give rise to the
syncytial phenotype, in which massive cell fusion was observed (Jacobson et al., 1989).
The UL34 gene product is a membrane phosphoprotein essential for viral replication in
cell culture as numerous attempts to delete it have been unsuccessful and is
phosphorylated by the HSV-1 protein kinase specified by the US3 ORF (Purves et al.,
1992; Roizman and Sears, 1996). The UL43 ORF gene product has not yet been
defined, but immunofluorescence studies have associated this protein with the Golgi
(Roizman and Sears, 1996). Interestingly, the UL43.5 ORF gene product which is
antisense to UL43 has been defined as a 38 kDa y protein that colocalizes with capsid
proteins in the nucleus of infected cells and functions as an accessory protein in capsid
assembly (Ward et ai, 1996). Visalli and Brandt (1993), characterized the UL45 gene
product as a membrane protein that functions to facilitate cell to cell fusion in HSV
infected cells as frameshift mutations in this gene result in a loss of immunodetectable
UL45 and the suppression of cell fusion caused by the syn3 mutation in gB (Haanes et
al., 1994).

Glycoprotein Trafficking
Previously mentioned studies of HSV envelopment and egress need to be
considered in the context of the intracellular macromolecular transport mechanisms.
HSV-1 like other animal viruses utilizes the host cell glycosylation machinery to
synthesize and process oligosaccharides attached to viral glycoproteins. The first steps
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in the eukaryotic secretory pathway is the targeting and translocation of nascent
protein precursors across the ER membrane and to the Golgi complex where posttranslational modifications occur. The processed glycoproteins are stored in
specialized secretory vesicles which then fuse with the cell surface during exocytosis
(Palade, 1975). The glycoproteins are synthesized as non-glycosylated precursors on
the rough ER (RER) and their N-terminal signal sequences target them to the lumen of
the RER, where oligosaccharide chains are added to the precursor proteins by
oligosaccharide transferases. The oligosaccharides are added en bloc from dolichol lipid
precursors in the lumen of the ER. There are two kinds of glycosylation in eukaryotic
cells, the N-linked glycosylation, where the sugars are linked via a N-glycosidic bond to
the Asn residue in the sequence Asn-X-Ser/Thr where X is any amino acid other than
Pro. The second kind of glycosylation occurs via a O-glycosidic bond to the hydroxyl
groups present in Ser and Thr residues (Hubbard and Ivatt, 1981; Rothman, 1994). Nlinked glycosylation is one of the most common post-translational modifications of
viral glycoproteins. The best studied model to date is the G protein of vesicular
stomatitis virus (VSV) (Rothman, 1994). Several approaches have been used to define
the functional roles of N-linked carbohydrate addition to glycoproteins. These
approaches include the use of agents that interfere with glycosylation, elimination of
each N-linked glycosylation site by site-directed mutagenesis, and the use of glycanprocessing deficient cell lines (Rothman, 1994). The oligosaccharides on the
glycoproteins play a significant role in initiation and maintenance of folding into
biologically active conformations, protecting polypeptides from proteolytic attack and
influencing the antigenicity and immunogenidty of the glycoproteins. Although the
functional contribution of the carbohydrates varies with the glycoprotein in question, it
has been generally accepted that glycosylation is necessary to aid proteins in attaining
and maintaining correct tertiary structures and in undergoing intracellular transport
(Kiely et al., 1976). The glycoprotein transport continues in electron dense vesicles
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budding from the RER which rapidly fuse with the ds-Golgi dstemae via a vesicle
targeting mechanism (Rothman, 1994). This vesicle shuttle allows transport between a
pair of membrane-bound compartments. One member of the pair, the donor
compartment, produces the transport vesicle and the other, the acceptor compartment,
receives the vesicle with the immature glycoprotein. The Golgi complexes are the sites
for sequential removal and addition of oligosaccharide residues that results in a final
high mannose glycoprotein (Hubbard and Ivatt, 1981; Spear, 1976). Transport of these
vesicles continues through the Golgi dstemae and eventually, the vesides bud from the
frans-Golgi network, reach the plasma membrane and fuse with it Brefeldin A, a fungal
metabolite that causes the retrograde movement of transport vesides from the Golgi to
the ER resulting in the dissolution of the Golgi stacks, also inhibits HSV-1 egress from
the cells (Cheung et al., 1991). Also, HSV-1 virions accumulate in gro29 cells, a cell-line
defective in Golgi processing and protein transport (Banfield and Tufaro, 1990; Tufaro
et al., 1987). Accumulation of virions in the cytoplasm was also observed in HSV-1
infected cells treated with monesin, an ionophore, that interferes with the processing
and transport of N-linked and O-linked HSV-1 glycoproteins (Johnson and Spear,
1982). Furthermore, wild-type HSV-1 infection of certain cell lines, such as Vero and
HEp-2, results in fragmentation and dispersal of the Golgi in the cytoplasm.
(Campadelli et al., 1993). Immunofluorescence studies against specific Golgi enzyme
markers revealed that these cytopathological changes occur late in HSV-1 infection and
may be caused by the overflow of viral glycoproteins as they traffic through the Golgi
complex (Campadelli et al., 1993). The UL20 gene product was required for egress of
infectious virions from Golgi fragmented cells (Avitabile et a i, 1994). Recently, genetic
approaches were used to eluddate the mechanism by which viral glycoproteins and
virions are trafficked through the celL Recombinant HSV-1 viruses with ER targeting
signals for gH were constructed, and it was shown that gH along with gL were not
processed and virions that were released from recombinant virus infected cells were
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devoid of gH and were noninfections (Browne et al., 1996). HSV-1 exploits the host cell
secretory machinery, however, it is unclear at the present time whether the mechanisms
for transport of viral proteins is s i m i l a r to that utilized for the transport of infectious
virions.

Virus - Induced Cell Fusion
Two important aspects of HSV-1 infection of cells in culture are viral entry and
viral spread. Both these processes involve distinct fusion events between the virus and
cellular membranes that occur dining viral entry and cell to cell fusion during viral
spread. A combination of virus-encoded membrane proteins and host cellular factors
contribute to both kinds of fusion events. Viral entry was reviewed in viral replicative
cycle. This section will focus on virus mediated cell to cell fusion which occurs dining
the transfer of virus from an infected to an uninfected neighboring cell as evidenced by
the formation of plaques in the presence of neutralizing antibody, hi cell culture, wildtype HSV-1 infections cause limited amounts of fusion, but, mutant viruses have been
isolated both in cell culture and in natural infections that cause extensive cell fusion
resulting in giant, multinucleated cells or syncytia (Brown et al., 1973; Hoggan and
Roizman, 1959; Person et a i, 1976; Spear, 1993). The mutations causing the syncytial
phenotype (syn) have been mapped to at least 5 distinct loci of the HSV-1 genome
(Figure 1.1). Using intertypic HSV-1 x HSV-2 mutants, Ryechan et al., (1979) were the
first to identify two major syn lod, the syn 1 and syn 3 loci, which were later shown to
be located in the genes coding for gK and gB, respectively (Bond and Person, 1984;
Bzik et al., 1984b; Debroy et al., 1985; Hutchinson et al., 1992b; Manservigi et al., 1977;
Pogue-Geile et al, 1984; Ryechan et al., 1979). The syn 2 domain was originally
mapped to the UL1 ORF which encodes gL (Little et ai, 1981), however, the mutation
has since been remapped to the gK gene (Roop et al., 1993). The syn 4 locus was
mapped to the UL20 ORF a gene that encodes a membrane protein, involved in virus
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egress in some cell types (Baines et al., 1991). Cells infected with mutant UL20-null
viruses form syncytia suggesting that this protein modulates fusion activity in infected
cells (Baines et al., 1991). The syn 5 locus affects the UL24 ORF, but its gene product
has not been characterized (Jacobson et al., 1989; Tognon et al., 1991). Finally, the
terminal repeats flanking the ULregions of the viral genome contains the syn 6 locus,
nestled between the genes encoding the ICPO and y 34.5 genes (Romanelli et al., 1991)
The best characterized syn loci are the syn 3 and syn 1 loci present in gB and
gK respectively. The syn 3 mutation affects the carboxy-terminal of gB and is the result
of an Arg to His change at amino a d d 875 in the (published) sequence of HSV-1 (KOS)
(Bzik et a l, 1984b; DeLuca et al., 1982; Kousoulas et al., 1982). In addition, certain
other point mutations between the amino add residues of 816 and 817 also cause the
syncytial phenotype (Bzik et al., 1984b). Studies using mutagenesis and truncations of
gB suggest that the carboxy-terminal 28 amino a d d s of gB are not essential for the
virus, although truncations cause extensive cell fusion (Baghian et al., 1993). To date
the majority of the syncytial mutants that have been characterized and mapped have
mutations in the synl locus present in the UL53 ORF encoding gK (Pogue-Geile et al.,
1984). These non-lethal amino add changes in gK are concentrated in two domains,
one at the amino-terminal and the other at the carboxy-terminal of the protein (Figure
4.1) (Dolter et al., 1994). In addition to the above mentioned proteins, the possibility
that other viral membrane proteins are indirectly involved in the fusion process emerges
from the observations that monoclonal antibody to at least three glycoproteins, gD
(Fuller and Spear, 1985), gH (Gompels and Minson, 1986) and gE, were found to block
fusion of the plasma membranes of infected cells. Furthermore, gE, gl, and gM and the
UL45 ORF, though dispensable for viral entry, are required for effident syncytium
formation by certain syncytial strains that contain the syn3 locus (Davis-Poynter et al.,
1994; Haanes et al., 1994; Visalli and Brandt, 1991). Interestingly, many gC negative
mutants are syncytial and conversely, many syncytial mutants have secondary
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mutations which inactivate gC (Bond and Person, 1984; Heine et al., 1974; Zezulak and
Spear, 1984) suggesting that gC modulates cell fusion, the exact mechanism of which is
unknown at the present time. Thus, Roizman, (1968) put forward a hypothesis that
postulated the existence of a complex of proteins involved in cell fusion, and
mutations or deletions of components of this complex could destabilize the complex
resulting in extensive cell fusion.

HSV-1 Glycoprotein K (gK)
This section details a review of the experimental work to date on glycoprotein K.
gK is the product of the UL53 ORF (Figure 1.5), the ninth HSV-1 glycoprotein to be
described (Hutchinson et a l, 1992b). The UL53 ORF nucleotide sequence was first
described by Debroy et al. (1985) as the gene that encodes a very hydrophobic protein
involved in virus induced cell fusion (Figure 1.6). Analysis of the UL53 coding
sequences reveals a G+C content of 61% compared to 67% for the total genome (Keiff
et a l, 1971). In vitro transcription and translation studies revealed that the 338 amino
ad d protein encoded by UL53 has characteristics of an integral membrane
glycoprotein, (as depicted in Figure 1. 5) in that it has 1) signal sequence at the Nterminus of the protein that is deaved between the Gly and Ala residues at amino
adds 30 and 31; 2) three potential N-linked glycosylation sites present in the amino
one-third of the protein, and 3) four hydrophobic domains, possibly functioning as
transmembrane regions to anchor the protein (Ramaswamy and Holland, 1992). In vivo
and in vitro studies of gK report that the processed UL53 gene product has a molecular
weight ranging 36 kDa to 40 kDa. There are conflicting reports regarding the kinetic
class (immediate-early, early, or late) to which gK belongs. Debroy et al., (1985)
reported UL53 mRNA was not detected in infected cells in the presence of
phosphonoacetic ad d (PAA), a viral DNA synthesis inhibitor, indicating the UL53
gene product to be a y protein stringently dependent upon viral DNA synthesis.
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Figure 1. 5: Predicted Primary Sequence of Glycoprotein K.
The protein sequence is shown with its signal peptide, the syn mutation at amino acid 40,the two
N-linked glycosylation sites and the hydrophobic domains are underlined.
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However, Hutchinson et al., (1992b) reported that gK was not sensitive to PAA
treatment and was regulated most likely as an early (a or {Dprotein. gK being a
hydrophobic protein has been difficult to detect in cell culture and in vitro translated
gK aggregates on heating (Ramaswamy and Holland, 1992). Immunopredpitations and
immunofluorescence studies with antibodies generated to synthetic peptides derived
from the antigenic portions of the primary gK sequence, detected low levels of gK in
infected cells. Furthermore, immunofluorescence microscopy of HSV-1 infected cells
and gK expressed from a recombinant adenovirus vector, localized gK to the
perinuclear, nuclear membranes and ER, but gK could not be detected in the plasma
membrane of infected cells. Also, gK was not detected in purified virion particles.
Interestingly, gK expressed in the baculovirus system had an apparent molecular
weight similar to that expressed in infected cells and was detected both in the nuclear
and plasma membranes of infected insect cells (Ghiasi et al., 1994). gK seems to be a
multi-functional protein involved in virus-induced cell fusion as a number of missense
syn mutations that cause the syncytial phenotype map to gK (Bond and Person, 1984;
Bond et al., 1982; Debroy et al., 1985; Dolter et al., 1994; Little and Schaffer, 1981;
Pogue-Geile and Spear, 1987; Read et al., 1980). Moreover, gK may be functioning in
viral entry as indirect evidence shows that gC negative viruses with the synl mutation
in gK are resistant to the inhibitory effects of heparin, infect gD expressing cell lines,
and thus they overcome gD-mediated interference (Pertel and Spear, 1996). These gD
expressing cell lines are normally resistant to wild-type HSV-1 infections and the block
appears to be at the level of penetration as the virus binds normally to these cells
(Warner et al., 1996). gK has also been implicated in intracerebral pathogenicity QQ of
HSV-1 as pathogenic strains of HSV-1 have mutations that map to the UL53 ORF
(Moyal et al., 1992). In an effort to determine if gK elicits neutralizing antibody and
cell-mediated immune responses like some of the other HSV-1 specified glycoproteins,
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ALIGNMENT OF GLYCOPROTEIN K SPECFIED BY SELECTED
ALPHAHERPESVIRUSES
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Figure 1.7: contd.
Figure 1. 7: Alignment of Protein Sequences of Glycoprotein K Specified By
Selected Members of the Subfamily Alphaherpesvirinae.
Sequences were aligned using the University of Wisconsin Genetic Computer Group
software package. Dots indicate gaps, upper case letters represent identical amino
adds to the consensus sequence and lower case letters represents mismatch amino
acids. HSV-1 = Herpes simplex virus type 1, HSV-2= Herpes simplex virus type 2,
BHV-1= Bovine herpes virus type 1, EHV-1 = Equine herpesvirus type 1,
PRV= Pseudorabies virus, VZV= Varicella zoster virus. Strain names are represented
in parenthesis.
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Figure 1.7
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gK was expressed in a baculovirus system, and the recombinant viruses were injected
into mice. gK-vacdnated mice were partially protected against lethal HSV-1 challenge,
despite the lack of a significant neutralizing antibody response. The mice vaccinated
with gK and occularly challenged with a stromal-disease-produdng strain of HSV-1
developed significantly more ocular disease than did identically challenged mockvaccinated mice (Ghiasi, 1996)
Initial attempts to delete the gK gene were unsuccessful indicating gK was
essential for viral replication (McLean et al., 1990). Recently a partially deleted HSV-1
mutant, F-gK0 was generated in which the ICP6::lacZ cassette was inserted into the
Hpa I site 336 nucleotides from the start of the UL53 ORF, thus allowing for the
expression of the amino-terminal one-third of the gK polypeptide (Hutchinson and
Johnson, 1995). F-gK{5 failed to replicate in Vero cells. The authors, on the basis of
electron microscopic studies, concluded that F-gKf) virions became enveloped by
budding through the inner lamellae of the nuclear membrane, but failed to translocate
from the perinuclear space resulting in the appearance of high numbers of unenveloped
capsids in the cytoplasm of cells. The hypothesis was proposed that in the absence of
gK viral envelopes fused in an unregulated manner with cytoplasmic membranes
resulting in the accumulation of unenveloped virions in the cytoplasm of Vero cells.
Significant homologs of gK have been identified in other herpesviruses including
herpes simplex virus -2 82.8%, (DebRoy, 1990), varicella zoster virus (Davison and
Scott, 1986), equine herpes virus-1 (Zhao et al., 1992), Marek's disease virus, 49.7%
(Ren et al., 1994) infectious laryngo tracheitis virus, 64.8%, (Johnson et al., 1995) and
bovine herpesvirus -1,46%, (Khadr et al., 1996) (Figure 1.7).
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CHAPTER n
HERPES SIMPLEX VIRUS TYPE-1 GLYCOPROTEIN K IS NOT ESSENTIAL FOR
INFECTIOUS VIRUS PRODUCTION IN ACTIVELY REPLICATING CELLS, BUT
IS REQUIRED FOR TRANSLOCATION OF INFECTIOUS VIRIONS FROM THE
CYTOPLASM TO THE EXTRACELLULAR SPACE
INTRODUCTION
Herpes simplex virus entry, nucleocapsid envelopment, egress, and transfer of
infectious virions from infected to uninfected cells involve fusion of cellular and viral
membranes that are thought to be regulated by membrane-associated virus-specified
proteins and glycoproteins (Roizman and Sears, 1996; Spear, 1993). Syncytial
mutations (syn) can arise in at least 4 different regions of the viral genome (Figure 1.1).
Syncytial mutations in UL53(gK) gene are more frequently isolated than syncytial
mutations in any other genes (Bond and Person, 1984; Bond et al., 1982; Debroy et al.,
1985; Dolter et al., 1994; Little and Schaffer, 1981; Pogue-Geile and Spear, 1987; Read
et al., 1980). Studies with anti-gK serum raised against peptides that represented
immunogenic portions of gK detected the glycoprotein in the nuclear and perinuclear
space, but not in the plasma membrane of infected cells. Furthermore, based on studies
with these anti-peptide sera, it is believed that gK is not part of the viral envelope
(Hutchinson et al., 1992b; Hutchinson and Johnson, 1995). Studies with virus mutants
have demonstrated that gD and the gH-gL complex are also required for virus entry
and cell fusion (Cai et al., 1988a; Cai et al., 1988b; Davis-Poynter et al., 1994; Forrester
et al., 1992; Ligas and Johnson, 1988). Moreover, evidence exists that gE, gL gM and the
UL45 protein are required for virus-induced cell fusion, because syncytial mutants in
gB do not cause fusion in the absence of these proteins (Balan et al., 1994; DavisPoynter et al., 1994; Haanes et al., 1994). However, others have reported that mutants
that lack gE (Neidhardt et al., 1987) or gl (Dingwell et al., 1994) retain the syncytial
phenotype, implying that the syncytial mutations were not located within the gB gene.

45
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Finally, cell factors have been shown to influence fusion of infected cells (Bzik et al.,
1984a; Serafini-Cessi et al., 1983; Shieh and Spear, 1994).

HSV-1 N udeocapsid Envelopment and Virion Egress
Herpesvirus capsids acquire their envelope by budding through the inner lamellae
of the nuclear membrane (Compton and Courtney, 1984; Morgan et al., 1959; Schwartz
and Roizman, 1969). The release of infectious virions from infected cells requires the
transport of infectious virions from the perinuclear to the extracellular space. The
translocation most likely occurs within transport vesicles derived from the outer
lamellae of the nuclear membrane and the contiguous ER (Campadelli-Fiume et al.,
1991; Compton and Courtney, 1984; Darlington and Moss, 1968; Morgan et al., 1959;
Roizman and Sears, 1996; Schwartz and Roizman, 1969). An alternative model has
also been proposed that involves de-envelopment at the outer nuclear membrane
followed by envelopment at the RER (Nii, 1992; Nii et al., 1968; Roizman and Sears,
1996; Stackpole, 1969; Whealy et al., 1991). Regardless of which model of transport is
correct, it is certain that intracellular virion particle transport is regulated by a number
of different proteins and other factors of cellular and viral origins. Specifically, in cells
defective in the processing of high-mannose precursor glycoproteins to mature
glycoproteins, or when Golgi-dependent functions are inhibited by the ionophore
monensin, infectious virions accumulate in the cytoplasm but are not transported into
the extracellular space (Banfield and Tufaro, 1990; Campadelli-Fiume et al., 1990;
Johnson and Spear, 1982) indicating that Golgi-dependent glycoprotein maturation is
vital for virion egress. gH must play an important role in egress of infectious virions,
since ts mutant viruses with mutated gH are retained within cells, while non-infectious
virions that lack gH are released by infected cells (Desai et al., 1988). Furthermore,
targeting gH to the RER with a specific retention motif KKXX results in virions released
by infected cells that are not infectious, while infectious virions that contain gH are
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retained in the cytoplasm (Browne et al., 1996). HSV-1 virions de-envelope in gD
expressing cells, indicating that gD can interfere with intracellular transport
(Campadelli-Fiume et al., 1991). The UL20 protein seems to be involved in a post
envelopment virion transport step, since UL20-null mutant viruses envelope in the
inner lamellae of the nuclear membranes, but are retained within the perinuclear space
of Vero cells. However, certain other cells are able to complement the UL20-null defect
and allow UL2Q-null virions to overcome this early block in the translocation pathway
indicating that cellular factors are involved (Avitabile et al., 1995; Baines et al., 1991;
McLean et al., 1990; Ward et al., 1994). Finally, gE and gl seem to play an essential role
in the basolateral spread of viruses in polarized cells (Dingwell et al., 1994; Roizman
and Sears, 1993).
To characterize the role of gK in virus replication and membrane fusion, a HSV-1
mutant virus AgK that lacks the entire UL53(gK) gene was constructed and
characterized. AgK virus is genotypically different from the previously reported F-gKp
mutant virus that was generated by insertion of an ICP6::lacZ cassette into the Hpa I
site 336 nucleotides from the start of the UL53 ORF, thus allowing expression of the
amino terminal one-third of the gK polypeptide (Hutchinson and Johnson, 1995). FgKP failed to replicate in Vero cells, and on the basis of electron microscopic studies, it
was concluded that F-gKp virions were able to envelope by budding through the inner
lamellae of the nuclear membrane, but failed to efficiently translocate from the
perinuclear space resulting in the appearance of high numbers of unenveloped capsids
in the cytoplasm of cells. By contrast to FgK-p, AgK virus replicated in sub-confluent
Vero and HEp-2 cells, and predominantly enveloped capsids were observed in the
cytoplasm of infected cells. In stationary Vero cells, AgK accumulated capsids in the
nucleus, and there was a concomitant decrease in the average number of enveloped
capsids in the cytoplasm. In addition, FgK-P produced partially syncytial plaques,
while AgK did not cause virus-induced cell fusion. These results indicate that gK is
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required for efficient virus envelopment and translocation of infectious virions to
extracellular spaces, and it further suggests that the observed phenotypic properties of
FgK-0 may be due to expression of the amino-terminal portion of gK.

MATERIALS AND METHODS
Cells and Viruses
African green monkey kidney (Vero), human epidermoid larynx carcinoma (HEp2) and rabbit skin cells were obtained from ATCC (Rockville, MD). Cells were
propagated and maintained in Dulbecco's Modified Eagles Media (DMEM; Sigma
Chemical Co., S t Louis, MO) supplemented with 10% heat inactivated fetal bovine
serum (FBS). V27 cells carry a stably integrated copy of the HSV-1 (KOS) ICP27 gene
and was kindly provided by Dr. D. M. Knipe, Harvard Medical School. These cells
were propagated in DMEM supplemented with 10% FBS (Rice and Knipe, 1990). The
VK302 cell line, a gK transformed cell line, was obtained from Dr. D. C Johnson,
Oregon Health Sciences University, and were maintained in DMEM lacking histidine
(GIBCO Laboratories, Grand Island, NY) and supplemented with 03 mM histidinol
(Sigma Chemical Co. St. Louis, MO). The cells were passaged once in DMEM plus 10%
FBS without selection prior to infection with virus (Hutchinson and Johnson, 1995).
HSV-1 (KOS), the parental wild-type strain used in this study was originally obtained
from Dr. P. A Schaffer (Dana-Faber Cancer Institute, Boston, MA). Viruses HSVl(KOS) d27-l has a 1.6 kb BamH I-Stu I deletion of the ICP27 gene was kindly
provided by Dr. D. M Knipe, Harvard Medical School and was propagated in V27
cells (Rice and Knipe, 1990). The gK mutant, F-gKp was a kind gift by Dr. D. C.
Johnson, Oregon Health Sciences University, and was propagated in VK302 cells
(Hutchinson and Johnson, 1995) (Figure 2.2).
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Reagents
Restriction enzymes, DNA modification enzymes and the Spe I* linker were
obtained from New England BioLabs (Beverly, MA). Deoxynudeotide triphosphates,
sequencing buffers and T7 DNA polymerase were from United States Biochemical
Corp. (Cleveland, OH) and were used in the dideoxy-chain termination method
according to manufacturer's instructions. Monoclonal antibodies mAb HS-B1 against
gB, mAb HS-Cl against gC, and mouse monospecific polyclonal antisera against gD
were produced in our laboratory by following standard procedures (Baghian et al.,
1993; Baghian et al., 1990). mAb 52-S against gH was obtained from ATCC (Rockville,
MD). 35S-methionine (13.62 mCi/mL) was from ICN Radiochemicals (Irvine, CA), and
35S-dATP sequencing grade(12.5 m Q /m L ) was from DuPont/NEN (Wilmington,
DE).

Plasmids
Plasmid pSG28 contains the EcoR IE-K fragments of HSV-1 (KOS) inserted into
pBR325 was a gift from Dr. R. M. Sandri-Goldin (University of California, Irvine, CA)
and was described previously (Goldin et al., 1981). The 3.2 kbp EcoR I-BamH I
fragment, which contains the carboxy-terminal two-thirds of the UL52 ORF and the
complete UL53 ORF, was removed from pSG28 and was inserted into the multiple
cloning site (MCS) of plasmid pUCl9 to generate plasmid pSJ1710 (Figure 2.1).
Plasmid pSJ1711 was derived from pSJ1710 and it contains an Spe I* linker
(CTAGACTAGTCTAG, that carries stop codons in all three reading frames and the
recognition sequence for restriction enzyme Spe D, at the unique Bbs I site (within the
UL53 ORF at nucleotide 75 from the start codon). A plasmid that contains the HSV-1
(KOS) BamH I-B fragment in pUC19 was kindly provided by Bill Goins (University of
Pittsburgh).
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Construction of Plasmid pSJ1724
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Figure 2.1: Schematic of Construction of Plasmid pSJ1724.
The relevant DNA fragments that were used to construct plasmids pSJ1711, pSJ1722, pSJ1723 and
pSJ1724 are shown, the cloning scheme is described in the text.
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Plasmid p6J1722 was derived from the BamH I-B by excising the BamH I-Pst I
fragment that contains the HSV-1 (KOS) UL54 ORF (coding for ICP27) and cloning it
into the MCS of pUC19. Plasmid pSJ1723 was derived by removing the BamH I-Hind
m fragment from pSJ1722 and inserting into BamH I-Hind HI site of pSJ1711, such as to
reassemble the UL52, UL53 and UL54 ORF in sequence. Finally/ the pSJ1724 was
derived by eliminating a 1 kbp Spe I-BamH I fragment from pSJ1723 that deleted the
entire UL53 ORF but kept the UL52 and UL54 ORFs intact (Figure 2. 2).

Construction of the gK-Null Virus (AgK)
Rabbit skin cells were transfected with plasmid pSJ1724 using the calcium chloride
precipitation method (Chen and Okayama, 1987) and 18 hours post transfection cells
were infected with d27-l (ICP27 null) virus, and the cells were lysed, and virus stocks
were made 24 hours post infection (h.p.i.). Viral recombinants were propagated on
Vero cells. Twenty five plaques were picked and plaque purified five times on Vero
cells.

Rescue of the gK-Null Virus Revertant Virus (AgK*)
Primers PI and P4 (Figure 2.3) were used to generate the 3.9 kbp PCR fragment
using wild-type KOS viral DNA as the template. Vero cells were transfected with the
wild-type KOS fragment using the calcium chloride precipitation method (Chen and
Okayama, 1987) and 24 hours post transfection, cells were infected with AgK virus.
Cell cultures were incubated at 37°C for an additional 48 hours at which point virus
stocks were prepared. Recombinant virus stocks were plated on subconfluent Vero cell
monolayers at different dilutions and allowed to replicate for 48 hours. Large wildtype plaques were picked and plaque purified three times.
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Viral DNA
Viral DNA was prepared in Vero cells as described previously (Kousoulas et al,
1984). Briefly, Vero cells were infected with plaque purified virus at an multiplicity of
infection (m.o.L) of 5. At 3 days post infection cells were lysed with 1% Nonidet * P40
(NP40) (Particle Data Laboratories Ltd. Elmhurst, IL.), 0.5% deoxycholic ad d (DOC)
(Sigma Chemical Co. St. Louis, MO) in 10 mM Tris, 1 mM ethylenediamine tetra acetic
ad d (EDTA) (both chemicals from Sigma Chemical Co. S t Louis, MO). Lysates were
treated with RNase (lOmg/mL) for 10 min. at 37°C, followed by addition of 1%
sodium dodecyl sulfate (SDS) (Sigma Chemical Co. St. Louis, MO) and proteinase K
(lOmg/mL) at 55°C, overnight. DNA was purified through two phenol ether
extractions and predpitated with 3M sodium acetate and ice cold ethanol To get
ultra-pure viral DNA, further purification through two Nal gradients was performed
(Kousoulas et al, 1984).

PCR Detection of gK-Null Virus
PCR was performed using the XL PCR kit supplied from Perkin Elmer as
described (Chouljenko et al., 1996). Viral DNA was prepared as described earlier.
Approximately 100 ng of viral DNA was used in a total reaction volume of 100 |il
PCR primers were PI (5' -GGC AAC GAC GAC GGG GAC TGG T-3'), P2 (5'-TGG
GTC CTC CTA CAG CTA), P3 (5' -GGC ACA GAC AAG GAC CAA TCA GAC
ACC A-3'), P4 (5’ -TCT CTC CGA CCC CGA CAC CAA-3') (Figure 2. 4). All the
primers were synthesized in our laboratory with a Perkin Elmer/Applied Biosystems
DNA Synthesizer, Model 394, using the phosphoramidite chemistry. The XL-PCR
reaction conditions were as follows: 94°C for 5 sec, 68° C for 8 min. for 30 cydes.

Southern Blot Analysis of Viral DNA
DNA from either KOS or AgK-infected Vero cells were extraded as described
previously. The purified DNA was digested with restriction endonuclease BamH I
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(New England Biolabs, Beverly, MA), electrophoresed on a 0.8% agarose gel,
transferred by Southern blot method (Southern, 1975), to positively charged nylon
membranes and hybridized with a biotin labeled probe. The probe was derived from a
3.2 kbp PCR fragment which contains portions of the UL52 ORF, the complete UL53
ORF and a portion of the UL54 ORF. The PCR fragment was purified and labeled with
biotin-dUTP using the NEBlot phototope kit (New England Biolabs, Beverly, MA.)
which incorporates biotin into the probe through a random primer reaction.
Prehybridization, hybridization and detection of the biotinylated probe was achieved
using the Southern-Light^^ chemiluminescent detection system according to
manufactures instructions (Tropix, Inc. Bedford, MA).

Visualization of Intracellular Virus Particles in Vero and HEp-2 cells Using Electron
Microscopy
Vero and HEp-2 cells were infected with AgK or wild-type KOS virus at an
m.o.i. of 10 and were incubated at 37°C for 48 hours. The infected cells were washed
three times with IX phosphate buffered saline (PBS) and fixed with 2% glutaraldehyde
in 0.1 M sodium cacodylate (CAC) buffer, pH 7.4 for 1 hour at room temperature.
Cells were then washed three times with 0.1 M CAC buffer supplemented with 5%
sucrose, pH 7.4 at room temperature and fixed with a 1% osmium tetroxide, 1%
potassium ferrocyanide solution for 1 and 1/2 hours. Cells were further washed three
times at room temperature with 5% sucrose in 0.1 M CAC buffer, stained with 2.5%
uranyl acetate in distilled water and refrigerated overnight Finally cells were washed
in distilled water and dehydrated using gradient steps of ethanol, then infiltered with
epon-araldite resin and polymerized for 24 hours at 60°C Sample blocks were
sectioned, mounted on grids and at least five sections and 10 different infected cells
per section were examined using a Philips 410 electron microscope for the presence of
viral particles (Cavalcoli et al., 1993).
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Kinetics of Infectious Virus Production
Sub-confluent Vero and HEp-2 cells were infected with either AgK, F-gKf), KOS, or
AgK* viruses at an m. o. L of 10. After a 60 min. adsorption at 4° C, unadsorbed
viruses were removed and cultures were washed with media. Fresh pre-warmed
medium was added to the cells, and cultures were incubated at 37°C for the duration
of the study. At selected times, the supernatants and the cell pellets were harvested
and collected in separate tubes. The samples were frozen and thawed three times,
sonicated on ice by pulsing 8 times with a microtip probe attached to a Branson
sonifier, cell disruptor 200 (Dansbury, CD and end-point plaque assays were carried
out on Vero cells.

Radiolabeling and Immunopredpitations
Conditions for radiolabeling and immunopredpitation were as described
previously (Baghian et al., 1992). Briefly, subconfluent Vero cells were infected at an m.
o. i. of 5 and labeled with 50 jxCi/mL 35s-methionine/cysteine mixture (ICN
Radiochemicals, Irvine, CA), from 6 to 24 h.p.L in methionine/cysteine-free media.
Cellular extracts were prepared and antibodies against gB, gC, gD and gH were used in
immunopredpitations following standard procedures (Baghian et al., 1993; Pereira et
al., 1980). Immunopreripitates were electrophoresed inSDS-PAGE gels as described
previously (Laemmli, 1970; Pereira et al., 1980).

RESULTS
Construction of the gK-null virus HSV-1 (KOS) AgK
HSV-1 (KOS)d27-l, a host-range mutant virus that carries a deletion in the ICP27
gene rendering the virus unable to replicate in Vero cells, while infectious virions can be
produced by complementation in the V27 cell line that is permanently transformed
with the ICP27 gene (Rice and Knipe, 1990) (Figure 2.2).
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Figure 2.2: Strategy for Isolation of HSV-1 AgK.
A) The top line represents the prototypic arrangement of the HSV-1 genome with
unique long (UL) and unique short (US) regions flanked by the terminal
repeats (TR) and internal repeats (IR) regions. Shown below is the region of
HSV-1 (KOS) genome (between map units of 0.7 and 0.8) containing the UL52,
UL53 and UL54 open reading reading frames with relevant restriction
endonuclease sites and the transcripts from the UL52, UL53 and UL54 ORFs.
B) Relevant genomic regions of the cell lines VK302 and V-27, viruses HSV-1 (KOS),
HSV-1 (d27-l) and the plasmid pSJ1724 employed in this study. Hypothetical
recombination between homologous regions of d27-l and plasmid pSJ1724 that will
result in AgK virus is depicted by dashed lines.
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Figure 2.3: PCR Detection of the AgK Genotype.
A) Region of KOS, d27-l (ICP27 null) and the AgK (gK null) viral
genomes containing the UL52, UL53 and UL54 open reading frames
with relevant restriction endonuclease sites and the relative positions of
the PCR primers. Open parentheses represent the portions of genes that
were deleted.B) List of the predicted PCR products from amplification
with each of the indicated PCR primer pairs. C) Agarose gel
electrophoresis of ds DNA PCR products. Lane 1: lambda phage DNA
digested with HindUI (marker). Lanes 2,3 and 4: Viral DNA of KOS,
AgK-1 and AgK-2 viruses amplified with PCR primer pair PI and P2,
respectively. Lanes 5,6 and 7: Viral DNA of KOS, AgK-1 and AgK-2
viruses amplified with PCR primer pair P3 and P4, respectively. Lane 8:
Molecular mass marker (1 kb ladder).
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Plasmid pSJ1724 was constructed to have a deletion of the entire portion of gK that
specified the mature g K Progeny recombinant viruses were expected to be generated as
a result of homologous recombination between the d27-l viral genome and the
transfected plasmid pSJ1724 in which the deletion in the ICP27 gene of the d27-l
genome was rescued by the intact ICP27 gene on the plasmid pSJ1724. ICP27 rescue
could only occur if the gK deletion was also transferred into the recombinant viral
genomes, since there were no homologous sequences between the gK and ICP27 genes
that could be used to independently rescue the ICP27 deletion (Figure 2.2).
Recombinant virus stocks plated on exponentially growing Vero cells, produced
two types of plaques on Vero cells; a wild-type size plaque composed of more than
100 infected cells and a smaller size plaque where 6*15 cells were recruited to form the
plaque. Putative recombinant viruses that formed large and small plaques on Vero cells
were isolated, plaque purified three times and the viral genomes from both kinds of
plaques were tested by diagnostic PCR.
Different sets of PCR primers were designed to detect either the gK-null or the
ICP27-null genotype. Primers PI and P2 were located within the UL52 coding
sequence, whereas primers P3 and P4 were located within the UL54-ICP27 coding
sequence (Figure 2. 3A). Primer P3 was located within the portion of UL54-ICP27 that
was deleted, while prim er P4 was located outside the deleted region (Figure 2 .3A).
The sizes of the expected PCR products from KOS, AgK or d27-l viral DNAs are
shown in Figure 2 .3B. PCR testing of the viral DNA samples obtained from
representative large plaques produced on Vero cells showed the presence of two viral
genotypes, the gK-null (AgK) and ICP27-null (d27-l) indicating that these plaques were
produced by Vero cells by mixed infections with these two viruses. Primer pairs P1/P4
and P2/P3 amplified DNA fragments of 3936 bps and 1604 bps, respectively, when
wild-type KOS was used as the control template DNA (Figure 2 .3C, lane 2 and lane
5). Viral DNA extracted from plaque-purified viruses obtained from the small plaques
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were subjected to diagnostic PCR. Primer pairs P1/P4 and P2/P3 amplified DNA
fragments of 2868 bp (Figure 2 .3C, lane 3,4) and 535 bp (Figure 2. 3C, lane 6,7),
respectively/ from the recombinant viral stocks indicating that these viral genomes
contained the expected deletion of the gK gene, while there were no contaminating
ICP27-null (d27-l) genotypes detected (Figure 2 .3 0 . Six such viral isolates obtained
from well-isolated and plaque-purified viral stocks were proven to contain exclusively
gK-null viruses. These virus isolates were designated AgK-1 through 6.
The genotype of representative gK-null viruses, AgK-1 and AgK-2, was confirmed
by Southern blotting (Figure 2.4). Viral DNA from KOS and AgK were digested with
the BamH I restriction endonuclease, separated by agarose gel electrophoresis and
transferred to a nylon membrane. The membrane was probed with a 3.2 kbp
biotinylated DNA fragment that contains the 3' third of UL52 ORF, the entire UL53
ORF and a portion of UL54 ORF (Figure 2.4B). The probe hybridized to two wildtype KOS DNA fragments, the BamH I-L fragment (53 kbp) which contains the UL52
and UL53 ORFs and the BamH I-B fragment (10.1 kbp) which contains the UL54 ORF
(Figure 2 .5a lane 5). As expected, the labeled probe hybridized to a single DNA
fragment of AgK of approximately 14.4 kbp. The DNA fragment represented BamH I-L
+ BamH I-B (5.3 kbp + 10.1 kbp = 15.4 kbp) - deletion in the gK gene (1.0 kbp) = 14.4
kbp. DNA sequencing revealed that the BamH I site joining the BamH I-L and -B DNA
fragments was lost in the engineered gK deletion resulting in the fusion of the BamH I-L
and-B DNA fragments (data not shown).

Rescue of the AgK Virus by DNA Fragments Spanning the gK Gene
To ascertain that the phenotype of the deletion mutant was due solely to the
deletion of the gK gene, marker-rescue experiments were performed with DNA
fragments that spanned the entire gK gene. Primers P2 and P3 were used to generate a
1. 6 kbp PCR fragment using wild-type KOS viral DNA as the template.
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Figure 2.4: Southern Blot Analysis of KOS and AgK Viral DNAs.
A) Lanes 1 and 5 are plasmids pBam HI-B and pRB126 digested with BamHI.
Digestion of these plasmids with BamHI results in the BamHI-B (10.2 kbp)
and BamHI-L (5.3 kbp) fragments respectively. Lanes 2,3 and 4 represent KOS,
AgK-1 and AgK-2 viral DNAs digested with restriction endonuclease, BamHI.
Lane 6, lambda phageDNA digested with restriction enzyme, HindHI.
B) Location of the 3.2 kbp biotinylated probe relative to the viral genome.
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The PCR amplified DNA fragment was transfected into Vero cells and 24 hours post
transfection, cells were infected with AgK virus. Approximately, 4% of the plaques
appeared larger than the typical small plaques produced by the AgK virus. A typical
virus plaque produced by the AgK revertant virus, designated AgK* is shown in Figure
2 .5B. Virus stocks were prepared from 4 different large plaques, and plaque-purified
three times. The DNA from these plaques was extracted and subjected to diagnostic
PCR All 4 viral DNAs were positive for the presence of the entire gK gene, and
indistinguishable from the wild-type KOS genotype. Furthermore, single step
replication kinetics of the AgK* virus was similar to that of the wild-type KOS.

Plaque Morphology of AgK and F-gKp Mutant Viruses on Different Cell Lines
The AgK virus was plated on exponentially growing Vero and HEp-2 cells (6070% confluent monolayers) and the resultant viral plaques were examined
microscopically three days post infection. AgK formed smaller plaques on HEp-2 cells
and Vero cells than the wild-type KOS virus (Figure 2 .5A and 2 .5C). The number of
infected cells that were found in these viral plaques ranged between 10-20, and the
plaques became first visible at 48 h.p.i., while KOS viral plaques were first visible at 24
h.p.L The average plaque size of AgK became larger with time and contained on the
average 40-50 cells at 72 h.p.L
Similar experiments were performed using confluent monolayers of Vero and HEp2 cells (cells seeded at 80-90% confluency). AgK produced small plaques on both cell
lines which involved 3-5 cells at 48 h. p. L F-gK(3 produced similar size plaques on
Vero cells, in agreement with a previous report (Hutchinson and Johnson, 1995). At
late times post infection, side-by-side comparison of AgK and F-gKp plaques on Iogphase Vero cells revealed that F-gKp plaques contained some fused cells, while AgK
plaques did n o t The phenotypic difference was even more pronounced at high m.o.L
with F-gKP producing small syncytia, while AgK did not cause any cell fusion.
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Figure 2. 5: contd.
Figure 2. 5: Plaque Morphology of KOS, AgK% AgK and F-gKP Viruses on Vero
Cells.
Panels A and B represent KOS and AgK* virus and panels C and D represent AgK and
F-gK(3 virus infected Vero cells, respectively. Cells were infected at an m. o. i. of 0.2
PFU/cell and photographed through a phase contrast microscope at 72 h.p.i.
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Figure 2.5
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Figure 2. 6: contd.
Figure 2. 6: Plaque Morphology of KOS, AgK*, AgK, and F-gK(3 Viruses on VK302
Cells.
Panels A and B represent KOS and AgK* virus and panels C and D represent AgK and
F-gKp virus infected VK302 cells, respectively. Cells were infected at an m. o. i. of 0. 2
PFU/cell and photographed through a phase contrast microscope at 72 h.p.i.
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Figure 2. 6
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The KOS and revertant AgK" plaques formed on VK302 cells were similar to those
obtained on Vero cells (Figure 2 .5A and 2 .5C). AgK produced larger, non-syncytial
plaques on VK302 (150 to 200 cells/plaque) when compared to Vero cells, however
these viral plaques were smaller than KOS or AgK" suggesting that AgK was not fully
complemented by VK302 cells (Figure 2 .6C). F-gKp produced partially syncytial, large
plaques on VK302 (Figure 2 .6D) as reported previously (Hutchinson and Johnson,
1995).

Propagation and Plaquing Efficiency of AgK and F-gKp on Different Cell Lines
A series of experiments were performed to compare the replication properties of
AgK and F-gKp mutant viruses in different cell lines. An equal number of infectious
virions obtained by titration on permissive cells, actively dividing Vero and VK302
cells for AgK and F-gKp, respectively, were used to infect both Vero and VK302 cells.
Virus stocks were collected and titered on log-phase Vero and VK302 cells. The results
of these experiments are shown in Table 2.1 A. AgK titers were approximately 100-fold
(2 logs) lower than KOS titers in actively replicating Vero cells, and 1,000,000-fold (6
logs) lower than KOS titers in stationary phase Vero cells (Table 2.1 A). Virus titers
obtained by propagation of AgK and F-gKp on Vero cells and subsequently titered on
VK302 cells were 100-fold(2 logs) and 10,000 (4 logs)-fold lower than KOS titers,
respectively (Table 2. IB). Furthermore, the average plaque size of AgK was larger (150
to 200 cells/plaque) than the average plaque of AgK produced on Vero cells (Figure 2.
5 and Figure 2. 6). F-gKp, and AgK viruses propagated on VK302 cells and titered on
VK302 cells produced approximately equal to KOS virus titers, indicating that VK302
cells complemented both gK-null viruses efficiently (Table 2. IB). The number of
infectious F-gKP virions produced by propagation of the virus on VK302 cells was
approximately 4-logs lower on Vero than on VK3Q2 cells, while AgK virus stocks
prepared on VK302 cells had similar titers on Vero and VK302 cells (Table 2. IB).
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Table 2.1: Plaquing Efficiency.
2. la
Virus*

KOS
AgK
FgK-P

Genotype Phenotype

Cells
Grown
On

Cells
Titered
On

Vero

Vero

gK'
gK*

Vero

VK302
Vero
VK302

Vero

Vero
VK302

gK' syn"
gK" syn*
gfCsyn"

3.2 x 103
7.7 x 107

2.9x10*
7.1 x 107

gK- syn
gfCsyn

3 x 102
6.5 x 10s

1.8 x 10*
4.5 x 107

g^
g^

gK" syn*

g^
gK-

Titer
Titer
Stationary
Log
PhaseCelis PhaseCelis
(PFU/mL) (PFU/mL)
5.5 x 10y
1.8 x lO*1*
7.7 x 10’
8.0 x 10’

2.1b
Virus*

Cells
Grown
On

Cells
Titered
On

Genotype

Phenotype

Titer
(PFU/mL)

KOS

VK302

Vero
VK302

g^
gK'

gK" syn"
gK" syn"

6 x 10iU
5.1 x 10’

Titer
Relative to
KOS on
VK302
Cells
11
1

AgK

VK302

Vero
VK302

gK- syn"
gfC syn"

1.3 x 10’
6 x 10’

0.25
1.17

FgK-P

VK302

Vero
VK302

g^
g^
gK-

gfCsyn

g^

gBCsyn

4.5 x 10s
7 x 10’

.00008
1.37

a Virus stocks from Vero cells infected with either KOS or AgK viruses, and VK302
cells infected with F-gKp virus were made and their plaquing efficiencies were obtained
on the indicated cells. PFU titers represent an average of three independent
experiments with individual titers varying less than 2-fold. Stationary phase cells were
approximately 2.5 x 106cells per 9.62 cm , and log-phase cells were 8 x 10s cells per
9.62 cm2well, respectively at the time of exposure to viruses.
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Kinetics of AgK and F-gKfi Infectious Virus Production
The kinetics of AgK infectious virus production was examined by measuring the
number of PFU at different times after infection. Equal numbers of subconfluent Vero
and HEp-2 cells were infected with mutant AgK and the wild-type KOS virus
respectively at an m.o.i. of 10. At various times post virus adsorption the cells were
harvested, viral stocks were prepared from cellular extracts and from the supernatant
fluids of infected cell cultures. The total number of plaque forming virions were
determined for each sample by titration on log phase Vero cells (Figure 2.7A). The
infectious virus production kinetics of AgK on Vero cells was markedly different from
the wild-type KOS virus, and the final number of infectious virions was approximately
two logs lower than that of KOS (Figure 2 .7A). Approximately 1000 infectious AgK
virions were found in the supernatant fluids at late times after infection, while the
number of infectious KOS virions released from infected Vero and HEp-2 cell
monolayers increased with time after infection reaching a maximum number that was
approximately 500,000-fold (5 logs) higher than the number of extracellular, infectious
AgK virions (Figure 2. 7A and 2 .7B).
A side-by-side comparison of the growth kinetics of AgK and F-gK0 virus was
performed (Figure 2 .7 0 . An equal number of infectious virions were used to infect
subconfluent Vero cell monolayers and the amount of virus produced at different times
was assessed by titrations on their respective permissive cell lines. AgK produced 2logs higher number of infectious virions than F-gK0. Infectious AgK and F-gKfl
accumulated exclusively within infected cells, while only a small fraction of the total
number of infectious virions was found in the extracellular fluids (Figure 2 7 0 .

Electron Microscopy
Conventional fixation-embedding electron microscopic analysis was undertaken to
identify the intracellular localization of AgK virus in Vero and HEp-2 cells.
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Figure 2.7: Kinetics of Infectious V irus Production.
Subconfluent Vero and HEp-2 cells containing approxim ately 8 x 10 5 cells per 9. 62 cm2 at the time of
infection(panels A and B) were infected at an m. o. i. of 10 with either KOS o r AgK viruses. Subconfluent
Vero cells (panel C) w ere infected at an m. o. i. of 10 with either AgK or F-gKp viruses. A t various times after
infection, virus stocks w ere prepared from the supernates and cell extracts and w ere titered on Vero cells.
Symbols: □ , extracellular KOS virus; O , cell associated KOS virus; A, extracellular AgK virus; O , cell
associated AgK virus;
extracellular F-gKp virus; H , cell associated F-gKp virus.

70

Intracellular virus was examined only in cells with morphologically intact nuclear
membranes to avoid studying late secondary cytoddal effects. The nuclei of all cells
were viewed at both 24 and 72 h.pi. appeared normal, exhibiting margination of the
chromatin along the nuclear membrane indicating that there was no destruction of
nuclear structures. In AgK-infected Vero cells there was an accumulation of naked (A
capsids), partially filled (B capsids) and completely DNA-filled capsids (C capsids)
capsids in the nucleus appearing in paracrystalline arrays proximal to the nuclear
membrane (Figure 2.8). Cells infected with the AgK virus revealed dilated perinuclear
vesicles, mitochondria and endoplasmic reticulum within the cytoplasm and very little
cytoplasmic virus was evident at 24 h. p. L However, at 72 h.p.L a small number of
completely enveloped capsids were visualized in the cytoplasm of infected cells (Figure
2.8B) while there were no virions observed in intercellular spaces. In contrast,
enveloped virus particles were detected in the cytoplasm and in tercellu lar spaces of
KOS infected Vero cells (Figure 2 .8C and 2 .12D). Electron micrographs of AgKinfected HEp-2 cells failed to reveal an unusually high number of capsids in the nuclei
of infected cells (Figure 2 .8E and 2 .8F), while enveloped virions were visualized in the
cytoplasm in clusters enclosed within vesicles (Figure 2 .8B). Intracellular spaces did
not contain any virion particles.

Characterization of AgK-Specified Glycoprotein Synthesis and Transport to the
Cell Surface
Subconfluent Vero cell cultures were infected with AgK virus at an m.o.L of 5 and
labeled with a ^m ethionine/cysteine mixture from 6-24 h.p.L Subsequently, infected
cells were collected and cell extracts were prepared. Specific antibodies against
glycoproteins gB, gC, gD, and gH were used in immunopredpitation experiments to
detect their presence in AgK-infected cell extracts. Immunopredpitates were analyzed
by polyacrylamide gel electrophoresis and autoradiographed.
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Figure 2. 8: Electron Micrographs of Vero and HEp-2 Cells Infected with AgK and
KOS Viruses.
Subconfluent Vero cells were infected with AgK virus (panel A and B), KOS virus
(panel C and D) and HEp-2 cells were infected with AgK virus (panel E and F). All
cells were infected at an m. o. i. of 10 PFU/cel1, incubated at 37°C for 72 hours and
prepared for electron microscopy. The arrows in panel A point to arrays of viral
capsids in the nucleus. Arrow in panel B point to a enveloped AgK virus in the
cytoplasm. Arrows in panel C mark the extracellular KOS virus. Arrows in panel D
point to KOS virions in the perinuclear space, cytoplasm and extracellular space. In
panel F the arrows mark AgK viruses found in the cytoplasm and unenveloped capsids
in cytoplasmic vesicles, n (nucleus), c (cytoplasm), e (extracellular space), scale bar =
0.5 pm.
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Figure 2. 8
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Figure 2. 8
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Figure 2. 9: Photograph of an Autoradiogram of Immunoprecipitates from Extracts
of Either KOS or AgK Virus Infected Vero Cells.
Lane 1: protein marker, Lanes 2 ,3 ,4 and 5 are KOS infected cellular extracts
immunoprecipitated with anti -gB, -gC, -gD and anti-gH antibodies, respectively.
Lanes 6,7,8 and 9 are AgK infected cellular extracts immunoprecipated with anti -gB,
-gC, -gD and anti-gH antibodies, respectively.
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Overall, viral protein synthesis in AgK-infected cells was reduced by approximately 5fold in comparison to KOS-infected cells. Therefore, five-fold more AgK-infected cell
extract was used for each glycoprotein immunopredpitation. Glycoproteins gB, gC, gD,
gH were detected in AgK-infected cell extracts (Figure 2.9). These results were in
agreement with indirect immunofluorescence assays that detected glycoproteins gB, gC,
gD and gH in AgK-infected cells. Transport of glycoproteins to the cell surface was
examined by fluorescent cytometry measurements using monoclonal antibodies to
glycoproteins gB, gC, gD and gH. All four glycoproteins were transported to the cell
surface.

DISCUSSION
A novel genetic approach was designed to produce the mutant virus AgK with a
deletion of the entire gK gene coding sequences specifying the mature gK. This report
demonstrates that gK is not essential for virus replication in HEp-2 and in
exponentially growing Vero cells, however, gK is required for virus replication in
stationary Vero cells. These results are consistent with a role for gK in virus
envelopment and translocation of infectious virions to extracellular spaces. The
collective findings and their interpretations are substantially different to those
obtained with the FgK-P mutant virus.

Construction of the AgK Virus
The isolation of the AgK mutant was accomplished by rescuing a deletion in the
ICP27 gene which is immediately adjacent to the gK gene, while simultaneously
transferring the engineered deletion in the gK gene. The absence of any intervening DNA
sequence between the gK and ICP27 deletions ensured that the d27-l defect could not
be rescued without the simultaneous transfer of the gK gene deletion (Figure 2.2).
Consistent with this, all putative recombinant viruses, tested after multiple plaque
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purification steps, were genotypically AgK. Construction of the gK gene deletion was
complicated by the presence of two absolutely essential genes (UL52, UL54-ICP27)
that flanked the gK gene. Furthermore, the UL52 ORF overlaps with UL53 ORF by 45
bp. A recombinant virus that preserved the UL52 gene, while deleting the entire gK
coding sequences that specified the mature gK was constructed successfully. The AgK
defect was rescued by a 1.6 kbp DNA fragment that encompassed part of the UL52
coding sequence and 250 bps of the upstream region of the ICP27 gene. It is unlikely,
that additional mutations were present in the carboxy-terminus of the UL52 gene that
may have contributed to the observed AgK mutant phenotype Furthermore, diagnostic
PCR failed to detect any additional gK deletions, and partial DNA sequencing of the
region immediately proximal to the 5' end of the gK gene deletion did not reveal any
point mutations (Figure 2.4).
The AgK virus is predicted to specify only the first 25 amino adds of the 30 amino
ad d signal sequence of gK The small polypeptide probably is directed to the
endoplasmic reticulum where it is eventually degraded as would be expected with the
normal gK signal peptide of 30 amino adds that is deaved off the translated gK
protein (Ramaswamy and Holland, 1992).

Role of gK in Virus Envelopment
Herpes virus capsids containing DNA are assembled in the nudeus and acquire
their envelopes by budding through the inner nudear membrane (Darlington and Moss,
1968; Roizman and Sears, 1996). Electron micrographs of AgK-infected Vero cells
revealed an unusually high accumulation of type "B" capsids juxtaposed to the inner
nuclear membrane. Visualization of predominantly "B" capsids in the nudei of AgKinfected Vero cells may indicate that viral DNA is not effidently packaged into
capsids. Additional experiments are needed to confirm any possible role of gK in DNA
packaging. A few fully enveloped and some partially enveloped viral partides were
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visualized in the cytoplasm of AgK-infected Vero cells at 72 h.p.L Approximately 10
enveloped virion particles were observed in the cytoplasms of each AgK-infected Vero
cell, and they were mostly found in membrane bound vesicles scattered in the
cytoplasm. By contrast to Vero cells, nudeocapsids did not accumulate in the nuclei of
HEp-2 cells, and approximately 100 enveloped virion particles were found in the
cytoplasm of HEp-2 cells. Viral yields (PFU/cell) were in agreement with the number
of enveloped virions found in the cytoplasm of each cell indicating that most of the
visualized enveloped viruses were infectious. These results suggest that the absence of
gK results in an inefficient capsid envelopment and reducing of the specific infectivity
of enveloped viruses.
Exponentially growing Vero cells released substantially more infectious virions in
their cytoplasms than stationary Vero cells, but 10-fold less than HEp-2 cells. This
indicated that actively replicating Vero cells, and HEp-2 cells complemented the gKnull defect for virus envelopment. HEp-2 cells are transformed cells originally isolated
from a human epidermoid larynx carcinoma (Moore et a l, 1955). In cell culture, HEp-2
cells remain metabolically active even at nearly 100% confluency as evidenced by the
fact that they incorporated ^m eth io n in e into their proteins, and ^H-Thymidine into
their DNA. Since glycoprotein K has been detected exclusively on the surface of nuclei
and ER membranes using anti-gK specific antibodies (Hutchinson and Johnson, 1995),
one can hypothesize that nuclear membranes of dividing cells may complement the
absence of gK because they are primed for mitotic division. In this hypothesis, gK may
cause similar nuclear membrane reorganization events to increase the efficiency of virus
envelopment Similar hypothesis to explain cellular complementation by exponentially
growing cells was reported for the HSV-1 strain 17 syn* ICP34.5 gene which codes for
a viral tegument protein, y 34.5. Deletion of the ICP34.5 (y34.5) viral gene in HSV-1
strain 17 syn* resulted in virions that failed to envelope, while capsids accumulated in
the nuclei of stationary phase 3T6 infected cells.
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However, the ICP34.5 null virus replicated efficiently in log-phase 3T6 cells (Brown et
al., 1994).
Role of gK in die Translocation of Infectious Virions from the Cytoplasm to the
Extracellular Space
Infectious AgK virions accumulated within the cytoplasm of Vero and HEp-2 cells
indicating that gK plays an important role in release of cytoplasmic virions to the
extracellular spaces. A similar retention of infectious virions within cells has been
noted when Golgi-spedfied enzymatic functions were inhibited either by Golgi-spedfic
inhibitors or in mutant cells deficient in specific Golgi-localized enzymes. These
observations suggest that translocation of infectious virions to the extracellular, free
spaces is Golgi-dependent. Our data are consistent with the view that transport
vesicles are formed by the outer nuclear lamellae, since AgK enveloped virions were
observed within cytoplasmic vacuoles. The defect in AgK egress, may be due to the
inability of these transport vesicles to carry their virion particle payload to the Golgi
apparatus. A corollary of this model is that gK-null virions in the cytoplasm of
infected cells should contain underglycosylated glycoproteins, since these precursor
glycoproteins are originating from the RER and the nuclear membrane. Such virions
were previously found to be infectious (Kousoulas et al., 1983). An alternative
explanation is that the absence of gK results in a general compromise of the structural
integrity of the virion particles that somehow alters their specific transport through the
Golgi-dependent secretory pathway. In support of this hypothesis, it has been
observed that the specific infectivity, and kinetics of entry of AgK virions are
substantially reduced in comparison to KOS virions (Baghian, et al personal
communication).
UL20 and gH are known to be involved in the transport of infectious virions to the
extracellular, free spaces (see literature review). UL20-null virions acquire envelopes in
Vero cells, but these get trapped within the perinuclear space (Baines et al., 1991).
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There are obvious similarities in virion transport defects caused by mutations in UL20,
gH and gK which imply that these proteins share some common functions in
intracellular virion transport. However, AgK virus is not complemented in many cell
lines including the 143 TK~ cell line that complements the UL20-null virus implying that
there are important differences between gK and UL20 functions. Mutant viruses that
carry a ts mutation in gH, synthesize at the non-permissive temperature immature gH
which is not transported to the cell-surface, and infectious virions accumulate in the
cytoplasm (Desai et a l, 1988). In contrast, gH is synthesized and expressed at the cellsurface of AgK-infected cells implying that gK's role in virion transport is different than
that of gH. As we have discussed earlier, available evidence indicates that glycoprotein
synthesis and cell-surface expression is associated with virion transport, since when
Golgi-dependent glycoprotein processing and transport was inhibited, it resulted in
inhibition of virion transport to extracellular spaces. Apparently the reverse situation
is not true, because glycoproteins gB, gC, gD, and gH are efficiently synthesized and
transported to the cell surface of AgK-infected cells. The AgK phenotype indicates for
the first time that viral glycoprotein transport and cell-surface expression can occur in
the absence of virion transport

Molecular Basis for the Genotypic and Phenotypic Differences Between AgK and
F-gKP Viruses
The genotypes of F-gKp and AgK mutant viruses are distinct F-gKp was created
by insertional inactivation of the gK gene using an ICP6::lacZ cassette (Goldstein and
Weller, 1988; Hutchinson and Johnson, 1995). The insertion allowed for the expression
of first 112 amino adds of gK fused to 26 amino adds originating from the 5'-most
DNA sequence of the ICP6 promoter of the ICP6::lacZ gene cassette The extra 26
amino a d d s that are fused to the amino terminal 112 amino adds of gK are: DPRARRF
CTWYSLT ASAGTR SCWCT (L. Hutchinson, personal communication).
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Acids Specified by F-gK[3.
Analysis were performed using the Protein Toolbox application of the MacVector
Software (IBI-Kodak).
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The amino add sequence was also independently predicted in our laboratory from the
complete ICP6:dacZ DMA sequence (S. Weller, personal communication). It was
hypothesized that this fusion protein is degraded because it does not contain the
hydrophobic portion of gK that is thought to anchor gK to membranes. Furthermore, it
was not possible to detect this truncated gK in FgK-p-infiected cells (Hutchinson and
Johnson, 1995). Interestingly, the 112 amino a d d sequence contains the synl locus that
demarcates the putative fusion domain of gK The 26 amino ad d segment that is fused
to the amino terminus of gK contains hydrophobic amino ad d segments which may
transiently anchor the gK-truncated protein to membranes (Figure 2.10). We
hypothesize that the different phenotypic properties of FgK-p and AgK viruses may be
due to expression of the truncated gK in FgK-p-infected cells. The specific phenotypic
differences between FgK-P and AgK mutant viruses are discussed in detail below:
Side-by-side comparisons of the replication and plaquing effidendes of AgK and
F-gKp mutant viruses on different cell lines showed substantial differences. F-gKp
failed to replicate as effidently as AgK virions, and did not form plaques as effidently
as AgK in Vero cell lines. F-gKp is derived from the HSV-1 (F) strain via a homologous
recombination with a plasmid derived from KOS genomic sequences in which a P~gal
cassette was inserted. HSV-1 (F) specifies gB that contains the fast-entry genotype that
causes faster kinetics of entry than KOS (Bzik et al., 1984b; Pellett et al, 1985), and the
kinetics of entry of F-gKp is faster than that of AgK virus on Vero cells (unpublished
observations). In this regard, F-gKp has an advantage for virus growth, since it enters
faster into cells than AgK virus, yet it replicated much less effidently than AgK virus.
These results suggest that the truncated gK oligopeptide-specified by F-gKp may
interfere with virus replication resulting in a substantial decrease of virus yields.
Comparison of F-gKP and AgK plaque morphologies revealed that F-gKP produced
partially syncytial plaques at late times post infection including the complementing cell
line VK302, while AgK did not produce syncytial plaques. The syncytial plaque
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phenotype difference between F-gKp and AgK viruses was particularly striking on gK-9
(gK-transformed Vero cell line) and 143 TK' (data not shown). These results suggest
that the putative F-gKp-spedfied gK polypeptide may associate transiently with
membranes causing cell fusion.
Electron microscopic examination of Vero cells infected with F-gKp virus showed
that F-gKp enveloped virions were predominantly found in the perinuclear space, and
a high number of capsids were also detected in the cytoplasm (Hutchinson and
Johnson, 1995). On the basis of these findings, it was suggested that gK may prevent
fusion between viral and cellular membranes, so that the virion particles do not loose
their viral envelopes during intracellular transport Our results with the AgK virus are
markedly different to these findings, since we did not observe neither enveloped virions
in the perinuclear spaces nor an unusually high number of capsids in the cytoplasm of
AgK-infected cells. We hypothesize that a partially functioning gK polypeptide
specified by F-gKp may result in the loss of viral envelopes via nonspecific fusion
events of viral envelopes with the outer lamellae of the nuclear membrane releasing
nudeocapsids in the cytoplasm.
Original descriptions of the syncytial phenotype attributed to the gK gene
induded the hypothesis that gK played the role of membrane fusion inhibitor or
modulator of virus-induced cell fusion. Thus, a gK-null virus would be expected to
cause syncytial plaques (Lee and Spear, 1980; Manservigi et al., 1977; Read el al., 1980;
Ruhlig and Person, 1977; Spear, 1993). Apparently, this hypothesis is not correct, since
AgK virions do not form syncytial plaques. The observation that the gK gene is the
favorite target for mutations that cause virus-induced cell-to-cell fusion, and the feet
that gK is involved in virus envelopment and intracellular virion partide transport
support a role for gK in multiple membrane fusion events. Eluddation of gK's role in
these membrane fusion events remains a crucial target in our quest to understand
herpesvirus maturation, virion transport, translocation of infectious virions to the
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extracellular space as well as in the ever elusive virus-induced cell to cell fusion
mechanisms, hi this regard, the availability of the AgK mutant virus in conjunction with
already developed methods for gK gene site-directed mutagenesis (Chouljenko et al.,
1996) will facilitate the delineation of the functional domains of gK.
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CHAPTER HI
VIRAL INTERFERENCE MEDIATED BY gK-TRANSFORMED CELL LINES TO
HSV-1 (KOS) EGRESS AND TO HSV-1 (AgK) REPLICATION
INTRODUCTION
HSV-1 Nudeocapsid Envelopment and Virion Egress
The final step in the morphogenesis of infectious HSV-1 virions is the acquisition
of the viral envelope by budding of DNA filled viral capsids through the inner lamella
of the nudear membrane (Roizman and Sears, 1993). The process is poorly
understood, but available data indicate that capsids and nudear membranes need to
be appropriately primed for effident virus envelopment Thus, defects in capsid
assembly or DNA encapsidation do not effidently produce enveloped virions
(Roizman and Sears, 1993; Spear, 1993). Similarly, defects in certain tegument proteins
that reside between the capsid and the viral envelope can also inhibit virion
envelopment (Roizman and Sears, 1993). Herpesvirus capsids acquire their envelope
by budding through the inner lamellae of the nudear membrane (Compton and
Courtney, 1984; Morgan et al., 1959; Schwartz and Roizman, 1969). The release of
infectious virions from infected cell requires the transport of infectious virions from the
perinuclear to the extracellular space. The translocation most likely occurs within
transport vesides derived from the outer lamellae of the nudear membrane and the
contiguous ER (Campadelli-Fiume et al., 1991; Compton and Courtney, 1984;
Darlington and Moss, 1968; Morgan et al., 1959; Roizman and Sears, 1996; Schwartz
and Roizman, 1969). The transport is modulated by both viral and cellular factors that
have been reviewed in Chapter I and Chapter IL One of the viral proteins that has been
directly implicated in transport is the UL20 protein. In the absence of UL20, virions
envelope, but remain in the perinudear spaces of Vero cells. However, most other cells
induding 143 TIC complement the UL20 defect indicating that Vero cells may lack
certain cellular factors that are involved in transport (Baines et al., 1991).
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Interference of HSV-1 Induced Cell Fusion by gB and gK-Transformed Cell Lines
Virus induced syncytium formation is mediated by intercellular recognition by the
virus-specified glycoproteins present on the plasma membrane by the viral receptors of
the adjacent cells. Wild-type infections in cell culture caused limited amounts of cell
fusion; however, mutant viruses were isolated that caused extensive cell fusion. The
syncytial phenotype was mapped to at least five different loci of the viral genome. The
predominant syn loci were present in genes that code for either glycoproteins or
membrane bound proteins. The syn 1 loci was mapped to the UL53 ORF that encodes
gK (Bond and Person, 1984; Debroy et al., 1985; Hutchinson et al., 1992b; Manservigi et
al., 1977; Pogue-Geile et al., 1984; Ryechan et al., 1979), syn 3 to the carboxyl terminal
of UL27 encoding gB (Bzik et al., 1984a), syn 4 was located in UL20 ORF (Baines et al.,
1991), syn 5 was present in the UL24 ORF (Jacobson et al., 1989; Tognon et al., 1991)
and syn 6 was mapped to the terminal repeat regions that flank the Ul, nestled
between the ICPO and y 34.5 genes (Romanelli et al., 1991). Cell to cell fusion induced
by mutant HSV-1 with gB or gK syn mutation were shown to be inhibited by cells
expressing the corresponding wild-type gB or gK proteins, respectively (Hutchinson et
al., 1993). Expression of wild-type HSV-1 gK suppressed membrane fusion induced by
syncytial mutants with mutations in gK but did not suppress fusion caused by
syncytial mutant with mutations in gB or vice versa. Also, inhibition of fusion was
shown to be dependent on the gK gen e-copy number. gK-transformed cell lines
decreased the viral yields and reduced the average plaque size in comparison to Vero
cells. These results indicate that both gB and gK play significant but separate roles in
virus-induced cell fusion.
To characterize the role of gK in virus replication and membrane fusion, we
previously constructed and characterized HSV-1 mutant virus AgK that lacks the entire
UL53(gK) gene (Jayachandra, S. et aL, submitted). AgK replicated in actively dividing
Vero and HEp-2 cells, and predominantly enveloped capsids were observed in the
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cytoplasm of infected cells. In stationary phase Vero cells, AgK accumulated capsids in
the nucleus, and there was a concomitant decrease in the average number of enveloped
capsids in the cytoplasm. In the process of generating the AgK viruses it was found
that the AgK virus could not be propagated efficiently on certain gK-transformed cells.
In particular, the AgK virus did not form plaques on BL-1 cells. The inability of BL-1
cells to complement the gK-null defect was further analyzed by examining the
replication properties of AgK and KOS virus on BL-1 and other gK-transformed cell
lines. This study shows that gK-transformed cells restrict virion egress of wild-type
HSV-1. Furthermore, AgK infectious virion production was restricted in gKtransformed cells.

MATERIALS AND METHODS
Cells and Viruses
Vero cells were propagated and maintained in DMEM supplemented with 10%
FBS (see chapter II materials and methods). Cell lines gB-gK and SV-gK, constructed in
our laboratory were maintained in DMEM supplemented in 10% FBS and 300 ug per
mL of G418 (Geneticin; GIBCO Laboratories, Grand Island, NY). BL-1 cells are Vero
cells transformed with HSV-1 (KOS) BamHI-L fragment was obtained from Dr. S. K
Weller (University of Connecticut Health Center) and was described previously
(Goldstein and Weller, 1988). These cells were grown in DMEM supplemented with
10% heat inactivated FBS and 250 ug per mL of G418. VK302 and gK-9 cell lines, are
two gK transformed Vero cell lines obtained from Dr. D. C Johnson, Oregon Health
Sciences University and were maintained in DMEM histidine minus medium (GIBCO
Laboratories, Grand Island, NY) supplemented with 10% FBS and 03 mM histidinol
(Hutchinson and Johnson, 1995). All transformed cells were passaged once in DMEM
containing 7% FBS without selection prior to infection with virus. The HSV-1 (KOS), the
parental wild-type strain used in this study was originally obtained from Dr. P. A
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Schaffer (Dana-Faber Cancer Institute, Boston, MA). AgK virus, a gK null virus, where
the entire gene coding for gK deleted was previously described (Figure 3.1)

Reagents
Restriction enzymes and DNA modification enzymes were obtained from New
England BioLabs (Beverly, MA).

Plasmids
Plasmid pSG28 contains the EcoRI E-K fragments of HSV-1 (KOS) inserted into
pBR325 was a gift from Dr. R. M. Sandri-Goldin (University of California, Irvine, CA)
and was described previously (Goldin et al., 1981). The 3.2 kbp EcoRI-BamHI
fragment, which contains the carboxy-terminal two-thirds of the UL52 ORF and the
complete UL53 ORF, was removed from pSG28 and was inserted into the multiple
cloning site (MCS) of plasmid pUC19 to generate plasmid pSJ1710. The 13 kbp Kpn IBamH I fragment from pSJ1710 was transferred to pUC19 to generate plasmid
pSJ1683. Plasmid pSJ1680 contains the 700 bp promoter region of HSV-1 gB derived
by PCR amplification of HSV-1 (KOS) viral DNA. The 700 bp fragment was PCR
amplified with a synthetic EcoR I at the 5' terminal and a BamH I site at the 3' terminal
to facilitate cloning into MCS of pUC19 to generate plasmid pSJ1680. The PCR primers
used to generate the 700 bp gB promoter were gBPl(5'-TAT CAA GAA TTC TCG
AGA AGA TGC TGC-3') and gBP2(5'-AAC TAA GGA TCC AGG GGG CCC GTC
GT-3'), respectively. The 1.3 kbp Kpn I-BamH I from pSJ1683 was excised, bluntended with T4 polymerase and cloned into the blunt-ended Pst I site in the MCS of
pSJ1680 to generate the plasmid pSJ1684. Thus, plasmid pSJ1684 contains the gene
coding for gK under the control elements of the gB promoter.
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p91023 is a eukaryotic expression plasmid that contains the SV40 origin of replication,
the adenovirus major late promoter coupled to the cDNA copy of the adenovirus
tripartite leader and the SV40 early polyadenylation signal (Wong et al., 1985). The 13
kbp Kpn I-BamH I fragment from pSJ1710 was blunt-end cloned into the blunt-ended
EcoR I site of p91023 to generate plasmid pSJ1720, thus placing the gK gene under the
control elements of the adenovirus major late promoter. pSV2rteo is a plasmid carrying
the dominant selectable neomycin resistance (NeoR) gene under the controls elements of
the SV40 origin of replication, SV40 promoter and the SV40 polyadenylation signals
(Qontech Laboratories, Inc. Palo Alto, CA).

Construction of gK-Transfonned Cell Lines, gB-gK and SV-gK
Cell lines gB-gK was constructed by cotransfecting subconfluent Vero cell
monolayers with 2 ug of plasmids pSJ1684 and pSV2neo and cell line SV-gK was
constructed by cotransfecting 2 ug of plasmids pSJ1720 and pSV2neo, respectively.
Transfections were carried out using the calcium phosphate precipitation method
described previously (Baghian et al., 1993; Chen and Okayama, 1987). Two days post
transfection cells were trypsinized and reseeded in the presence of selection media
(DMEM supplemented with 10% FBS and 150 ug/m L G418). Cells were selected for
neomycin resistance using increasing amounts of G418. Individual colonies of cells were
picked, grown and subcloned three times, checked for the presence of gK by PCR,
before establishing these cell lines for further experiments.

Genomic DNA
Genomic DNA was extracted from the cell lines by lysing the cells w ith 1% NP40,
0.5% deoxycholate in 10 mM Tris, 1 mM EDTA (TE). Lysates were treated with RNase
(lOmg/mL) for 10 min. at 37°C, followed by addition of 1% SDS and proteinase K
(lOmg/mL) at 55°C overnight DNA was purified through two phenol ether extractions

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

91
and precipitated with 3M sodium acetate and ice cold ethanol. The precipitates were
resuspended in distilled water and was used in PCR and dot blot assays.

Cellular RNA
Total RNA from BL-1 and Vero cells was extracted using the Tri-Reagent kit
according to manufactures instructions supplied by (Molecular Research Center, Inc.
Cincinnati. OH). RNAs were suspended in 10 mM Tris, 1 mM EDTA pH 8.0 buffer
and used in dot blot assays.

PCR Detection of the gK Gene in gK-Transformed Cell Lines
PCR was performed using the GeneAmp Reagent kit supplied by Perkin
Elmer/Applied Biosystems (Foster City, CA). Genomic DNA was prepared as
described above. Approximately 100 ng of cellular DNA was used in a total reaction
volume of 100 uL. PCR primers FF1 (5'-TACCCTGCAGCAGCA AAGCCT-3') and FF2
(5'-TGCGTAGTTCAAGAGGTAGGT-3'). All the primers were synthesized in our
laboratory with a Perkin Elmer/Applied Biosystems DNA Synthesizer Model 394
using the phosphoramidite chemistry. The PCR reaction conditions were as follows:
98°C for 1 sec, 58° C for 1 min., 72° C for 2 mins for 30 cycles, followed by a 5 min.
extension at 72° C.

Dot Blot Hybridization of Cellular DNA and RNA
Total cellular DNA from Vero, gB-gK, SV-gK and BL-1 cells were extracted
as described previously. The purified DNA was treated with 0.4 mM sodium
hydroxide, lOmM EDTA for 30 mins. at 37°C. The denatured DNA solution was
applied to the positively charged nylon membrane present in the dot blot manifold
(Bio-Rad Laboratories, Hercules, CA) according to manufactures instructions. For
northern dot blot hybridization, total cellular RNA from Vero and BL-1 cells were
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denatured with lOmM sodium phosphate, dimethyl sulfoxide (DMSO), 6M glyoxaL
After blotting the membranes were rinsed gently with 2X SSC (sodium chloride and
sodium citrate buffer), air dried, and hybridized with a biotin labeled probe. The probe
was a 13 kbp Kpn I-BamH I fragment derived from plasmid pl683 which contains
portions of the UL52 ORF and the complete UL53 ORF. The 13 kbp fragment was
purified using Prep-A-Gene DNA purification systems according to manufactures
instructions and labeled with biotin-dUTP using the NEBlot phototope kit (New
England Biolabs, Beverly, MA.) which incorporates biotin into the probe through a
random primer reaction. Prehybridization, hybridization and detection of the
biotinylated probe was achieved using the Southern-Light"^ chemiluminescent
detection system according to manufactures instructions (Tropix, Inc. Bedford, MA).

Kinetics of Infectious Virus Production
Sub-confluent monolayers of Vero, BL-1 VK302 cells were infected with either AgK
and KOS at an m. o. L of 10. After a 60 min. adsorption at 4° C viruses were removed
and cultures were washed with media. Fresh pre-warmed media was added to the
cells and cultures were incubated at 37°C for the duration of the study. At selected
times, the supemates and the cell pellets were harvested to separate tubes. The
samples were frozen and thawed three times, sonicated and plaque assay were carried
out on Vero cells.
Visualization of Intracellular Virus Particles in Vero, BL-1 and VK302 Cells Using
Electron Microscopy
Vero, BL-1 and VK302 cells were infected with AgK or wild type KOS virus at an
m. o. L of 10, incubated at 37°C for 48 hours and were prepared for electron
microscopy as described in material and methods in Chapter II.
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RESULTS
Glycoprotein K (gK) - Transformed Cell Lines
Initial attempts to inactivate the gK gene failed indicating that gK may be essential
for virus replication (MacLean et al, 1991). To assess the role of gK in HSV-1
replication a number of gK-transformed cells were used. BL-1 cells were transformed
with the HSV-1 (KOS) BamHI-L DNA fragment containing the entire gK gene and
portions of the adjacent DNA sequences representing the portions of the UL51 and the
entire UL52 ORF (Goldstein and Weller, 1988). The UL52 ORF specifies a subunit of
the helicase-primase complex that is essential for viral DNA replication. BL-1 cells
efficiently complemented the UL52 defective virus, h rll4 and the copy number was
established 5-10 copies per cell (Goldstein and Weller, 1988). In addition, two stably
transformed gK cell lines, gB-gK and SV-gK were constructed (Figure 3.1). The
presence of the gK gene in the gB-gK and SV-gK cell lines were detected by PCR gK
gene specific PCR primers were used to amplify the gK gene from the transformed cell
lines (Figure 3.2). Results show that a 1.1 kbp was amplified, similar to the control
BL-1 cells. The copy number of the gK gene in both cell lines were established by dot
blot hybridization. The copy number of BL-1 was previously established to be 10-15
copies per celL By comparison to BL-1 cells the copy number of gB-gK and SV-gK cells
was established to be 15 copies and 8 copies per celL
Two additional gK transformed cells, VK302 and gK-9 were later obtained from
Dr. D. C. Johnson. In both VK302 and gK-9 the cellular copy of gK is under the control
elements of the HSV-1 gD promoter and the bovine growth hormone polyadenylation
signals. The exact copy number of gK in VK302 cells is not known, however, the VK302
cells partially complements gK-null virus, AgK and FgK-p. The expression of gK in
VK302 was estimated to be similar to the levels of wild-type HSV-1 infections in Vero
cells (Hutchinson and Johnson, 1995). In gK-9 cells the copy number of the gK-gene was
estimated to be over 200 copies per cell (Hutchinson et a l, 1993).
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Figure 3. 2 : PCR Detection of the gK Gene in Transformed Cell Lines.
Agarose gel electrophoresis of ds DNA PCR products to detect the gK genotype.
Lane 1 through 5: cellular DNA from gB-gK cells; Lanes 6 through 9: cellular DNA
from SV-gK cells; Lane 10: Viral DNA of KOS. All DNA were amplified with gK gene
specific PCR primer pair PI and P2, respectively. Lane 11: lambda phage DNA
digested with HindO (marker).

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

95

A)

1

4

5

6

t t •
•
Vero

#
BL-1

UL54-ICP27

UL53-gK

UL52

B)

•

« ///////>
BamHI

EcoR I

Kpnl

J,
Bbsl

»
Hpal

BamHI

Biotinylated probe
(5.6 kb)
Figure 3.3: Northern Dot Blot Analysis of Vero and BL-1 cellular RNAs.
A) Duplicate samples of RNA from Vero cells(Lane 1) and BL-1 cells (Lanes 4,
5 and 6) were blotted onto nylon membranes and probed with the biontylated
probe.
B) Location of the 5.6 kbp biotinylated probe relative to the viral genome.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

96

mRNA Synthesis in BL-1 cells
mRNA was extracted from non-infected BL-1 and Vero cells and Northern dot
analysis was performed as described in materials and methods. Results showed that
biotinylated gK DNA probe hybridized to mRNA from BL-1 cells whereas the probe
did not bind to Vero cell RNA extracts (Figure 33)

Plaque Morphology
In the process of generating a gK-null virus, the recombinant AgK stocks were
plated on Vero and BL-1 (Figure 3.4). AgK produced numerous small plaques on
actively dividing Vero cells (5-10 infected cells/plaque) as previously reported
(Jayachandra, S. et aL, submitted). The viral recombinants did not produce plaques
when propagated on confluent BL-1 cell monolayers. At high m. o. L individual
rounded up cells infected cells were visualized at late hours post infection in AgK
infected BL-1 cells. However, from 72 hour post infection (h. p. L)., small numbers of
microscopic plaques (5-10 cell infected cells/ plaque) were visualized when AgK was
propagated on actively dividing BL-1 cells. Wild-type KOS virus plaques were reduced
in size when propagated on confluent or actively dividing BL-1 cells when compared to
the plaque size on Vero cells (Figure 3.4). The plaque morphology of AgK and KOS
was examined on SV-gK, gB-gK and gK-9 cell lines and in these gK-transformed cells
AgK produced microscopic plaques, however, the KOS plaques were similar to those
on BL-1 cell monolayers. Furthermore, the plaque morphology in AgK infected VK302
was larger with 50-100 infected cells/plaque thus indicating to some partial
complementation of the gK-null defect However, the wild-type KOS plaque size was
reduced when compared to Vero cells (Figure 2.6).
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Figure 3. 4: contd.
Figure 3. 4: Plaque Morphology of KOS and AgK Viruses on Vero and BL-1 Cells.
Panels A and B represent KOS and AgKvirus infected Vero cells and panels C and D
represent KOS and AgKvirus infected BL-1 cells, respectively. Cells were infected at an
m. o. i. of 0. 2 PFU/cell and photographed through a phase contrast microscope at 72
h. p. i.
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Table 3.1: Flaqtiing Efficiency on gK-Tranformed Cells
Virus*

Cells Titered
On

Genotype

Phenotype

Titer
PFU/mL

KOS

Vero

gK+

gK+syn+

2x 10l°

VK302

gK+

gK+syn+

5 x 10*

gB-gK

gK+

1 x 10*

BL-1

gK+

gK+syn+
g
K+syn+

5.3x 10*

SV-gK

gK+

gK+syn+

4 x 10*

gK-9

gK+

gK+syn+

3 x 106

Vero

gK-

gK syn+

4x 10*

VK302

gK-

gK syn+

6x 107

SV-gK

gK-

gK syn+

1.2 x 10s

gB-gK

gK-

gK syn+

3 x 10*

gK-9

gK-

gK syn+

4x 10*

BL-1

gK-

gK syn+

2.6x 101

AgK

“Virus titers represent an average of three independent experiments with
individual titers varying less than 2-fold. KOS and AgK viral stocks were prepared
in Vero and titered on the indicated cell lines.
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Plaquing Efficiency of AgK and KOS on Different gK -Transformed Cell Lines
The replication properties of AgK and KOS in the gK-transformed cells was
determined in a series of titration experiments. AgK and KOS viral stocks obtained by
propagation on the permissive actively dividing Vero cells, were used to infect
subconfluent Vero, BL-1, SV-gK, gB-gK, gK-9 and VK302 cells. The results of these
experiments are shown in Table 3.1. KOS titers were reduced by 10-fold (1 log) in
VK302 and gB-gK cells; 100-fold (2 log) in BL-1 and SV-gK cells and 10,000 fold (4
logs) in gK-9 cells. The AgK viral titers in Vero cells were reduced by 100 fold(2 logs)
when compared to KOS titers in Vero cells. However, all the gK-transformed cells
showed varying decrements in titer when infected with AgK virus. In VK302 cells, AgK
titers were reduced 10 fold (1 log); in SV-gK the titer reduced by 1000 fold (3 log);
10,000 fold (4 log) reduction was observed in gB-gK and gK-9 cells and in BL-1 cells
the reduction in titer was 100,000 (5 log) when compared to the AgK in Vero cells
(Table 3.1).

Replication Kinetics of AgK and KOS in Vero, BL-1, and VK302 Cells
To further elucidate the replicative characteristics of AgK and KOS, one-step
replication curves were established on Vero, BL-1 and VK302 cells (Figure 2.7; 3 .5A
and 3 .5B). Previously, we have reported that the infectious virus production kinetics
of AgK was markedly different from that of wild-type KOS virus, and that over time
there was an accumulation of virions in the cytoplasm of cells (Figure 2.7). In VK302
cells the replication kinetics of AgK revealed an increase in the accumulation of
infectious virions in the cytoplasm over time, with a 2 log difference in the titer between
extracellular and intracellular virions (Figure 3 .5B). In BL-1 cells, KOS infectious
virions accumulated inside the cells with a 6-log drop between the extracellular virus
and the amount of cell associated virions.
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Figure 3.5: Kinetics of Infectious V irus Production in BL-1 an d VK302 Cells.
Subconfluent BL-1 and VK302 cells containing approxim ately 8 x 10 ^ cells per 9.62 cm^ at the tim e of
infection(panels A an d B) were infected at an m. o. i. of 10 w ith either KOS or AgK viruses. At various times
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cells. Symbols: □ , extracellular KOS virus; O , cell associated KOS virus; A, extracellular AgK virus; O , cell
associated AgK virus;
extracellular F-gKp virus; SJ, cell associated F-gKp virus.
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The AgK replication was greatly reduced compared to KOS, and the titers of both the
extracellular and intracellular virus remained constant at approximately 1000
PFU/mL (Figure 3 .5A).

Electron Microscopic Examination of KOS and Agk on Vero, BL-1 and VK302 Cells
AgK infected Vero cells revealed an accumulation of capsids in the nucleus, a few
enveloped particles in the cytoplasm and the extracellular spaces devoid of virions as
previous reported (Figure 2.8). Wild-type KOS virus replicated efficiently in BL-1 cells
(Table 3.1). However, electron microscopic analysis of KOS infected BL-1 cells
revealed an accumulation of enveloped virus particles in the perinuclear space, while
a few enveloped virions were found in the cytoplasm and intercellular spaces (Figure 3.
6A). In contrast, examination of more than 100 different AgK-infected BL-1 cells
revealed that most cells did not contain any virion particles (Figure 3. 63), while 2% to
4% of the cells contained a small number of capsids within their nuclei and some
aberrant enveloped virions in the cytoplasm (data not shown). In VK302 cells both
AgK and KOS capsids were seen in the nucleus (Figure 3 .7A and 3 .7B). Enveloped
AgK and KOS virions were visualized in the perinuclear spaces, cytoplasmic transport
vesicles and in the extracellular spaces (Figure 3 .7A and 3 .7B).

D IS C U S S IO N

Partial Complementation of AgK in VK302 Cells
Preliminary evidence demonstrated that the gene encoding gK, the UL53 ORF
could not be deleted and it was hypothesized that this gene product was essential for
viral replication (MacLean et al., 1991). Also, F-gKp, a partial gK-null virus (the gK
gene was insertional inactivated with a p-galactosidase gene) could not be propagated
on Vero cells but replicated efficiently, on VK302 cells.
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Figure 3. 6: Electron Micrographs of BL-1 cells Infected with AgK and KOS Viruses.
Subconfluent BL-1 cells were infected with KOS virus (panel A) and withAgK virus
(panel B) at an m. o. L of 10 PFU/cell, incubated at 37°C for 72 hours and prepared
for electron microscopy. The arrows in panel A point to multi-laminar structures
formed by the nuclear membranes. n=nudeus, c=cytoplasm, scale bar = 0.5 pm.
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Figure 3.7: Electron Micrographs of VK302 Cells Infected with AgK and KOS
Viruses.
Subconfluent VK302 cells were infected with KOS virus (panel A) and with AgK virus
(panel B) at an m. o. L of 10 PFU/cell, incubated at 37°C for 72 hours and prepared
for electron microscopy. The arrows in panel A and B points to extracellular virus.
n=nucleus, c=cytoplasm/ scale bar = 0.5 pm.
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However, the gK-null virus, AgK (with the entire gene coding for gK deleted) was
isolated in the absence of a complementing cell line and gK was shown to be
dispensable for viral replication in actively dividing cells (Jayachandra, S et aL,
submitted). Interestingly, certain gK-transformed cell lines, BL-1, gK-9, gB-gK and SVgK, restricted the replication of AgK virus. The possibility that gK-transformed cells
can neither complement nor inhibit gK-null viruses was examined in detail previously
(Hutchinson et al, 1993; Hutchinson and Johnson, 1995). A rather complicated picture
emerged from those studies. F-gKp failed to form plaques on Vero cells, formed
syncytial plaques in cell lines that expressed low amounts of gK, and its replication
was inhibited in cell lines expressing high amounts of gK in comparison to wild-type
levels. However, F-gKp was able to efficiently replicate in the VK302 cell line that
produced intermediate amounts of gK similar to the levels produced by wild-type
infections (Hutchinson and Johnson, 1995). Enveloped KOS virus was found in the
perinuclear spaces and in the cytoplasm of infected VK302 cells (Figure 3.7), however,
there was a 10-fold decrease in infectious virions between extracellular and
intracellular virions (Figure 3. 5B). This aspect is similar to the reported phenotype of
wild-type KOS virus infections in VK302 cells (Hutchinson and Johnson, 1995).
Suprisingly, VK302 efficiently complemented both the gK mutant viruses, F-gKp and
AgK virus, although the viral yields were reduced in comparison to wild-type
(Hutchinson and Johnson, 1995); Jayachandra, S., submitted), while BL-1 and the other
gK-transformed cells did not efficiently support the replication of AgK virus. One
possible explanation of these differences between different cell lines is that in VK302
and gK-9 cells the gK gene is under the control of the HSV-1 gD promoter whereas in
BL-1 cells the gK gene is under its own promoter, in SV-gK and gB-gK cells, gK is under
the control elements of adenovirus major late promoter and gB promoter, respectively.
The difference between VK302 and gK-9 cells was that the latter had over 200 copies
of the gK gene per cell whereas VK302 cells expressed similar to wild-type levels of gK
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(Hutchinson and Johnson, 1995). Therefore, differential expression due to different
promoter controls may not be responsible for the observed phenotypic differences.
An alternate explanation is that the gK gene that is expressed in VK302 cells
has secondary mutations that overcome the gK-mediated interference. This kind of
restriction has been previously reported for gD-transformed cells. HSV-1 gD
transformed Vero cells inhibits wild-type HSV-1 and HSV-2 infection in several cells
lines (Campadelli-Fiume et al., 1988; Dean et al., 1994; Johnson and Spear, 1989). Most
likely the presence of the expressed wild-type gD precludes penetration of virus into
cells by interacting directly with the virion or by interfering with virus binding to the cell
surface receptors (Dean et al., 1994). Mutant viruses that overcome the gD-mediated
interference have mutations mapping to gD and/or to the gK and gC genes. These
HSV-1 gD mutants that overcome gD mediated interference de-envelope in gD
expressing cells, and there was a 50% reduction in infectious virus in the extracellular
fluids compared to wild-type virus indicating inefficient cellular transport and egress
(Campadelli-Fiume et al., 1990). Furthermore, cells transformed with mutated form of
gD do not restrict wild-type or the gD mutant replication, indicating that mutated form
of gD expressed by these transformed cells does not block the relevant entry. Similarly,
VK302 cells can be postulated to posses second site mutations in gK that help
overcome the restriction to both wild-type virus and AgK virus replication. Currently,
we are in the process of sequencing the gK gene from VK302 cells.

Virus-Induced Cell Fusion in gK-Transformed Cells
Previously it was reported that gB-transformed cells inhibited the fusion caused
by the syncytial mutants with mutations in gB and that gK-transformed cells inhibited
fusion caused by syncytial viruses with mutations in gK (Hutchinson et al., 1993).
Interestingly, viral induced cell fusion was not drastically inhibited in BL-1 infected
with syncytial mutants HSV-1 (MP) or HSV-1 (fsB5). However, infectious viral titers
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of HSV-1 (MP) were reduced by 100-fold when compared to KOS infected BL-1 cells
and HSV-1 (tsB5) viral titers were similar to KOS titers (Jayachandra et al., 1995). The
inhibition to fusion was at low m. o. L, at high m. o. L viral fusion induced by these
syncytial mutants were not inhibited. Moreover, like wild-type virus, BL-1 cells
infected with syncytial mutants accumulated virions in the nucleus and perinuclear
membranes and no virus was visualized in the cytoplasm or the extracellular spaces of
infected cells implicating defects in post-perinuclear egress defects (Jayachandra et al.,
1995). Furthermore, the synthesis of viral glycoproteins in KOS infected BL-1 cells were
reduced by 3-fold compared to KOS-infected Vero cells.

Restriction of AgK Virus Replication in BL-1 cells and O ther gK-Transformed Cell
Lines
BL-1 cells that are transformed with the HSV-1 (KOS) BamHI-L fragment
containing the entire UL52 and UL53-gK genes did not support the replication of AgK
(Figure 3 .5A). Wild-type KOS virus replicated on BL-1 cells, however, KOS viral titers
were reduced by two logs when compared to Vero cells (Table 3.1). Electron
microscopic examination of KOS infected BL-1 cells revealed an unusual accumulation
of enveloped virions in the perinuclear space, while there were few enveloped virions in
the cytoplasm and on the surface of infected cells (Figure 3.6). In agreement with the
electron microscopic results, the growth kinetics on BL-1 showed an accumulation of
infectious virions in the cells, with no accumulation of virus in the extracellular fluids.
The phenotypic property is reminiscent of the UL20-null phenotype that caused
accumulation of enveloped virions in the perinuclear space in Vero cells and HEp-2
cells but not in 143TK\ (Baines et al., 1991). A possible interference by UL52
expression in BL-1 cells can be ruled out since BL-1 cells efficiently complement the
UL52-null virus, h rll4 (Goldstein and Weller, 1988). Furthermore, BL-1 cells are
transformed with 10-15 copies of the gK gene which is under the control elements of its
own promoter. Also, other gK transformed cells with the exception to VK302 behaved
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like BL-1 cells. It is unlikely that BL-1 cells express high amounts of gK, yet it severely
restricts the replication of AgK virus. Also electron microscopic visualization of AgK
infected BL-1 cells did not detect an accumulation of virions in the nucleus, perinuclear
spaces or in the extracellular spaces (Figure 3.6). The level of cellular host-range
restriction provided by BL-1 cells on AgK virus replication is unusually severe, since
viral titers were reduced by 5 logs when compared to KOS titers (Table 3.1)
The mechanism of gK-mediated restriction was further investigated by analyzing
various gK-transformed cells with the gK gene under different transcriptional
promoters. KOS infectious virus production in the gB-gK and SV-gK cells were
marginally reduced, with a 2-fold and 10-fold decrease, respectively (Table 3.1).
However, in gK-9 cells (a gK transformed cell line with 200 copies of the gK gene/cell)
the KOS viral titers were decreased by 1000-fold. Electron microscopic examination of
wild-type HSV-1 strain F, infected gK-9 cells showed an accumulation of enveloped
virions in the perinuclear spaces with no virus detected in the cytoplasm (Hutchinson
and Johnson, 1995). It was postulated that the over expression of gK in gK-9 cells was
detrimental to wild-type HSV-1 egress which resulted in the reduction in infectious
virion production. Interestingly, preliminary evidence shows the wild-type entry
kinetics in gK-transformed cells is delayed when compared to KOS entry in Vero cells,
however, immunofluorescent studies of gB expression revealed that there was a 5-fold
reduction either in the transport of the virions to the nucleus or a decrease in overall
viral protein synthesis (Baghian et al., 1997).
Interference to AgK virus replication in BL-1 and the gK-transformed cell lines
could be explained by the fact that these gK-transformed cells consdtutively express
low amounts of gK which are expressed in nuclear membranes and possibly other
intracellular membranes in the absence of viral infection. The idea is supported by
northern blot studies that indicated low amounts of gK transcripts in uninfected BL-1
cells (Figure 33). Presumably, the KOS virus is able to overcome the fnms-dominant
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inhibitory effect of low amounts of gK expressed in BL-1 cells. The early presence of gK
in BL-1 cells inhibits the translocation of virion particles from the perinuclear spaces to
the cytoplasm, thus effectively trapping enveloped virions in the perinuclear space. In
the case of AgK virus, the absence of viral gK gene expression, causes maximum
inhibition of AgK virus in BL-1 cells. It is not clear at the present time what step of the
AgK virus replication cycle in BL-1 cells is affected by this trans-dominant inhibition of
virus replication.
Wild-type virus, syncytial mutants and AgK infectious virion production was
reduced in gK-transformed cells, however, AgK infectious virion yield was significantly
reduced by 1000-10,000 fold. Moreover, virtually no capsids accumulated in the nuclei
of BL-1 cells infected with AgK virus which may implicate that this resistance by gKtransformed cells to AgK infection may be due to a multitude of cellular and viral
specified factors. Available data with anti-peptide gK serum, revealed that gK was not
detected in the plasma membrane or in the virion particle and that gK localized to the
RER, Golgi apparatus and the nuclear membranes (Hutchinson et al., 1995). One can
postulate that gK may be functioning in virus entry, and the gK-specified by the gKtransformed cells may be interacting with host cellular factors like the recently
described accessory protein, HVEM (Montgomery et al., 1996). Herpes virus entry
mediator (HVEM), a HeLa cell cDNA when stably expressed transfers susceptibility
to HSV-1 entry to the normally resistant Chinese hamster ovary (CHO) cells. HVEMtransformed cells were shown to enhance entry of a variety of HSV-1 strains and is
implicated to mediate post-attachment events (Montgomery et al., 1996). Interestingly,
the syncytial mutant virus, HSV-1 (MP) that has the syn 1 mutation in gK and is gC
negative, enters and replicates albeit inefficiently in CHO cells that were normally
resistant to HSV-1 wild-type. However, in HVEM transformed-CHO cells, the entry of
HSV-1 (MP) was significantly enhanced which raises the possibility that some other
cell-specified accessory factors may be mediating the entry of syncytial mutants. In gK-
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transformed cells this interaction could be at an earlier event occurring during the
glycoprotein processing and maturation of both the cellular HVEM-like mediator and
the cell-specified gK. The interaction could render the HVEM-like mediator inactive/
precluding infection by AgK mutants. However, the binding of the accessory entry
mediator may not be absolutely essential for entry of wild-type strains, which have
been shown to enter gK-transformed cells, although with slower entry kinetics (Baghian
et a l, 1997)
An alternate explanation is that the gK antipeptide serum could not efficiently
detect the mature form of gK that may be present in the virion particle or in the plasma
membrane of infected cells. The gK specified by these transformed cells may interfere
with HVEM or other unidentified gK-spedfic plasma membrane receptor resulting in
the inaccessibility of this portal of entry by AgK virions. The low amounts of gK that
are expressed in gK-transformed cells can partially block receptors, and incoming wildtype virus overcomes this block or uses alternate entry pathways due to presence of
functional gK
A second possible explanation is that transport of virions from the plasma
membrane to the nucleus may be significantly delayed in gK-transformed cells.
Preliminary evidence shows that wild-type KOS has a 2 hr delay in the synthesis of
glycoproteins in gK-transformed cells (Baghian et al., 1997). The transport of AgK
virions in gK-transformed cells may be delayed even further, and the viral capsids may
not form the appropriate post-entry intermediates required for progress of virion
particles to the nucleus which could result in the AgK virions being directed to
endosomes and lead to their eventual degradation as evidenced by wild-type KOS
infections of gD transformed cells.
The third possibility is that AgK viral capsids are blocked from docking at the
nuclear membrane, while KOS viral capsids enter the nucleus and viral replication
ensues. The absence of gK in AgK virions may alter the tertiary structure of the virion

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

113

particle that enables the recognition of nuclear receptors. The possibility that the viral
DNA encoded by AgK is defective is unlikely, because the AgK virions are able to enter
Vero and HEp-2 cells normally and establish efficient replication.
Lastly and more importantly, gK plays a crudal role in virion egress and may
modulate this pathway. The intracellular vesicular pathway comprises a series of
membrane bound compartments between which the vesicles are shuttled during the
process of transport of macromolecules. One important aspect of this pathway is that
macromolecular synthesis and transport originating in the ER must be transported,
sorted and distributed by transport vesicles to their correct destinations. The process
thus requires a machinery that is responsible for the formation, targeting (pilots and
sorters) and fusion of transport vesicles. HSV-1 may utilize this vesicular pathway to
egress from cells, indicating that certain viral factors either mimic or act in coordinance
with cell factors to facilitate virion intracellular transport In wild-type infected gKtransformed cells virions accumulate in the perinuclear spaces, reminiscent of the
UL20-null virus. In the previous chapter it was reported that AgK virions are most
likely transported in vesicles derived from the outer nuclear lamella, but in the absence
of gK these vesicles failed to correctly transport the virion particles to extracellular free
spaces. Interestingly, in gK-transformed cells these outer lamella derived transport
vesicles are not formed, resulting in accumulation of wild-type virions in the
perinuclear spaces. These results are consistent with the role of gK in formation of
transport vesicles from the outer lamella and the subsequent piloting and or/sorting of
such vesicles to the Golgi and eventually to the plasma membrane. Further, it points to
a possible role for nucleus-bound factors that are needed for transport vesicle
formation, and in gK-transformed cells such cellular factors are inhibited by the early
expression of cellular gK
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CHAPTER IV
SITE-DIRECTED MUTAGENESIS OF THE AMINO TERMINAL OF HSV-1 GK
INTRODUCTION
HSV-1 glycoprotein K is involved in viral envelopment and virion egress, as
reported in the previous chapters. gK is also involved in modulation of viral induced
membrane fusion events (reviewed in detail in literature review). The syn 1 loci maps to
gK and this locus can be further separated into two syncytial domains, one domain
located at the amino terminal a t/o r around amino add 40 and the other located
towards the carboxy terminal of gK (Dolter et al., 1994) (Figure 1.5 and Figure 4.1). A
number of syncytial mutants have mutations mapping to the N-terminal of gK (Bond
and Person, 1984; Bzik et al., 1984b; Debroy et al., 1985; Hutchinson et al., 1992b;
Manservigi et al., 1977; Pogue-Geile et al., 1984; Ryechan et al., 1979). Five of eight such
mutants were N-terminal domain mutants (Dolter et al., 1994). Four of the five HSV-1
(MP), HSV-1 (KOS) syn 20, syn 102 and syn 105 have mutations at amino ad d 40 of
the primary sequence of gK (Figure 4.1). In all mutants except syn 20, the change was
from Ala 40 to Val 40. In syn 20 the mutation was from Ala 40 to Thr 40. The single
point missense mutations that resulted in these amino add substitutions rendered the
virus to cause extensive cell-cell fusion or syncytia. In cell culture, infections with MP,
syn 102, and syn 105 were considered to be dominant as they caused extensive
(strong) fusion, whereas infections with syn 20 were considered to be weakly
codominant because the plaques were only partially fused (Dolter et al., 1994).
Another syncytial mutant virus HSV-1 (KOS) syn 8 has amino add substitution at
position 33, that results in a Pro 33 to Ser 33 change. This mutant has two additional
mutations in gK that may or may not be related to the fusion phenotype. However, the
Pro 33 to Ser 33 is a drastic change from small nonpolar, helix breaker to a more
hydrophilic polar amino add.
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Figure 4.1: contd.

Figure 4.1: Alignments of Protein Sequences of gK Specified By Different
HSV-1 Syn Mutants.
Sequences were aligned using the University of Wisconsin Genetic Computer Group
software package. Dots represent amino adds identical to the parental wild-type
HSV-1 KOS sequence. Uppercase letters denoted below the wild-type HSV-1 KOS
sequence represent mismatch amino adds. " * " depicts the mutated amino adds that
result in the syncytial phenotype.
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.............................................
.............................................
.............................................
.............................................

HSV-1 (KOS)
HSV-1 (MP). Syn 1
HSV-1(KOS). Syn 8
HSV-1(KOS). Syn 20
HSV-1(KOS). Syn 30
HSV-1(KOS). Syn 31
HSV-1(KOS). Syn 102
HSV-1(KOS). Syn 103
HSV-1(KOS). Syn 105

201
250
ETDPVTFLYH RPAIGVIVGC ELIVRFVAVG LIVGTAFISR GACAITYPLF
ML.......................
.............................................
.............................................
.............................................
.............................................
.............................................
.............................................
.............................................

251
300
HSV-1(KOS)
LTITTWCFVS TIGLTELYCI LRRGPAPKNA DKAAAPGRSK GLSGVC®CC
HSV-1(MP). Syn 1
.............................................
HSV-1(KOS). Syn 8.................................................
HSV-1(KOS). Syn 20
.............................................
HSV-1(KOS). Syn 30
.............................................
HSV-1(KOS). Syn 31
.............................................
HSV-1(KOS). Syn 102 .............................................
HSV-1(KOS). Syn 103 .............................................
HSV-1(KOS). Syn 105.. .............................................

301
*

338
*

HSV-1 (KOS)
SIILSGLAMR LCYIAWAGV VLVALHYEQE IQRRLFDV
HSV-1 (MP) . Syn 1....
V..........................
HSV-1(KOS). Syn 8......................................
HSV-1(KOS). Syn 20
..................................
HSV-1 (KOS). Syn 30
.. .P...............................
HSV-1(KOS). Syn 31
..................................
HSV-1(KOS). Syn 102 ..................................
HSV-1 (KOS) . Syn 103 ...... L .........................
HSV-1(KOS). Syn 105 ..................................

Figure 4.1
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In vitro transcription, translational and truncation experiments have also shown
that gK has a signal peptide that is cleaved at amino add 30, has two N-linked
glycosylation sites at amino add position 48 and 58, respectively, and the first
hydrophobic domain anchors the amino one-third of the protein to membranes
(Ramaswamy and Holland, 1992) (Figure 1.5). Considering all these facts it was
suggested that residues 31 to 124 form the ectodomain of gK and is probably involved
in viral induced cell fusion.
In an attempt to rapidly delineate and map the functional domains that are
involved in virus-cell fusion and in viral egress, a long-PCR site-directed mutagenesis
method was developed that results in nearly 100% mutagenesis of the final DNA
products (Chouljenko et al., 1996). The method utilizes long-PCR enzymes and
conditions to efficiently amplify DNA fragments. The long PCR fragments carrying
specific mutations could efficiently recombine with intact viral DNA in the novel
recombinant system that was developed in chapter 2. This procedure of creating sitespecific mutations was demonstrated by generating a new restriction endonuclease site
and a missense mutation in the glycoprotein K(gK) gene specified by herpes simplex
virus (HSV-1). A recombinant virus that carried the mutated gK gene caused extensive
cell fusion of infected cells (Chouljenko et a l, 1996). Using this long PCR site-directed
mutagenesis procedure three different mutations were introduced into the gK gene, such
that the translated gK proteins would have amino a d d substitutions at Ala 31 to Val
31, Thr 50 to Val 50 and Thr 60 to Val 60.

MATERIALS AND METHODS
Cells and Viruses
Vero, rabbit skin cells and V27 cells were obtained and maintained as
described previously (Chapter 2 materials and methods). HSV-1 (KOS), the parental
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wild-type virus strain and HSV-1 (KOS) d27-l were propagated in Vero and V27 cells
respectively (Chapter 2 materials and methods).

Equipment and Reagents for PCR
All experiments were performed using the GeneAmp PCR System 9600 according
to manufacturers instructions (Perkin Elmer Corporation, Norwalk, CD. All PCR
reagents were provided as part of the XL PCR Kit (Part No. N808-0182; Perkin
Elmer/Applied Biosystems, Foster City, CA). Hot Start PCR was performed with
Ampli Wax PCR Gem 50 (Part No. N808-0150; Perkin Elmer/Applied Biosystems,
Foster City, CA).

Restriction Enzymes and Plasmid
Restriction enzymes Bam HI, Bbs I and Kpn I were obtained from New England
BioLabs (Beverly, MA). Plasmid pSJ1710 described previously (Chapter 2 materials
and methods) contains the 3.2 kbp EcoR I-BamH I fragment, which contains the
carboxy terminal two-thirds of the UL52 ORF and the complete UL53 ORF. The
plasmid was digested with Kpn I-BamHI to generate a 1340 bp DNA fragment that
was used as a 'cast7 DNA.

Primers for Long PCR and Mutagenesis
Primers LN5 (5’- GGC AAC GAC GAC GAC GGG GAC TGG T-3’), C3 (5’-GGC
CTT GGA ACG GGG ACG GAT TTA T-3’), Mutagenic primer-MUTl (5’-CCG TCT
TTG GTG TCA GTC CGC TGC A-3% Mutagenic Primer-MUT2 (5’-TGC AGC GGA
CTG ACA CCA AAC ACG G-3’), P2 (5'-TGG GTC CTC CTA CAG CTA-3') and P3
(5' -GGC ACA GAC AAG GAC CAA TCA GAC ACC A-3') were synthesized in our
laboratory with a Perkin Elmer/ Applied BioSystems DNA Synthesizer Model 394
using phosphoramidite chemistry. The approximate location of primers LN5, C3,
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MUT1 and MUT2 and the gK gene on the viral genomic map is shown in Figure 4.2.
The PCR fragment produced by the LN5 and C3 primer pair was predicted to be 4314
bps-long with an average GC content of 65.2%. The DNA fragment amplified by
LN5/MUT2 primer pair was predicted to be 1156 bp with a GC content of 64.4%, and
the PCR primer pair MUT1 /C3 produced a product of 3183 bps with a GC content of
65.6%. Primers P5 and P6 bracket the point mutation and were used for detection of
the engineered mutation in mutant viruses (Figure 4.2).

Extension of the LN5/MUT2 PCR Product Using the Cloned gK DNA Fragment or
"cast*
The template wild-type KOS viral DNA was prepared as described in materials
and methods of chapter 2. The 1130 bp PCR fragment derived from the primer pair
LN5/MUT2 (500 ng) was mixed with the cloned Kpn I-Bam HI DNA fragment (125
ng), denatured and reannealed. The total volume of DNA mixture was brought up to
55.6 mL and the parameters for extension were: Extension reaction mix (100 mL):
DNA solution (55.6 ml), Mg(OAc)2 (4.4 ml), 3.3X XL buffer (30.0 ml), dNTPs, (8.0 mL
of 2.5 mM-stock), rTth, XL (2.0 ml). Thermal profile: 3' at 95°C; 1' at 94°C, and 15' at
72°C for 7 times.

Final Overlap-Extension
The LN5/MUT2 PCR extended product (50 ng) was gel-purified vising the PrepA Gene purification method as detailed by the manufacturer (Bio-Rad, Inc, Richmond,
CA), and was used for the next overlap-extension with the MUT1/C3 product (50 ng).
Extension reaction mix (100 ml): DNA solution (55.6 ml), Mg(OAc)2 (4.4 ml), 3.3X XL
buffer (30.0 ml), dNTPs (8.0 mL of 2.5 mM stock), rTth, XL (2.0 ml). Thermal Profile:
3’ at 95°C; 1' at 94°C, and 15' at 72°C repeated 3 times.
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Long PCR Mutagenesis Procedure
(a )

Location of primers on the HSV-1 viral genome
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Figure 4.2: Schem atic D iagram of th e M utagenesis Procedure.
A) The HSV-1 genom e show ing the location of all the prim ers and the gK gene.
The location of the engm eeredm utaion is denoted(A). (B an d C) The
L N 5/M ut2 PCR product (B) and the M u tl/C 3 PCR product (C). (D) The
cloned DNA gK fragm ent used for the first extension reaction. (E) The first
extension reaction (— )of the L N 5/M ut2PC R product using the d o n e d gK
DNA fragm ent. (F) The extensionof the PCR product from step E using the
PCR DNA fragm ent represented in step (C). (G) The final PCR pro d u ct using
prim ers LN5 and C3. This DNA fragm ent contains the desired m utation (A).
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Final PCR Conditions
The primer pair LN5/C3 was used to amplify the 4279 bp DNA fragm ent PCR
parameters were: 3' at 95°C; 30' at 94°C, 8' at 68°C repeated 30 times, a n d final
extension for 15' at 72°C. Hot Start conditions were applied according to the
Manufacturer (Perkin-Elmer/Applied Biosystems) and the composition of lower and
upper reaction mixtures were as follows: Lower Reaction Mixture (40 ml-total): water
(12.4 ml), 3.3X XL Buffer (12.0 ml) dNTPs (8.0 mL of 2.5 mM stock)), Prim er LN5 (1.6
mL of 20 mM stock), Primer C3 (1.6 mL of 20 mM stock), Mg(OAc)2, (4.4 mL of 25
mM stock). Upper Reaction Mix (60 ml): water (38 ml), 33X XL Buffer (18 ml), viral
DNA (1 mL of 7 mg/ml-stock), rTth DNA PoL XL (2 mL of 2 U/ml-stock).

Generation of Recombinant Virus and Detection of Site-Specific M utation
Rabbit skin cells were transfected with the mutagenized long PCR fragment
using the calcium phosphate technique (Chen and Okayama, 1987) and twenty four
hours post transfection cells were superinfected with d27-l viruses. Forty eight hours
post infection, recombinant viral stocks were made and titered on Vero cells. For PCR
analysis, viral DNA mini-preparations were prepared from plaque-purified virus
stocks as described previously (Chapter 2 materials and methods). Viral DNAs from
each of the viral plaques were subjected to PCR analysis using internal gK primers P2
and P3 and the subsequent PCR products were digested with restriction endonuclease
Bbs I.

RESULTS
PCR M utagenesis
A pair of mutagenesis primers MUT1 and MUT2 were designed such that a Ala
to Val change was created at position 30 of the gK primary sequence and also the
existing cleavage site for the restriction enzyme Bbs I was obliterated.
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1 2 3 4 5 6

7 8 9 1 0 1 1 1 2 13 14

Figure 4.3: Agarose Cel Electrophoresis of Viral PCR Products Restricted with
Bbs L
P5/P6 PCR products from putative mutagenized SJVal31 virus (lane 2 thro 9),
laboratory virus strain KOS (lane 10 thro 13). PCR DNA fragments were digested with
restriction endonuclease Bbs I (lanes, 3,5,7,9,11 and 13 respectively). Molecular
weight marker, X phage DNA digested with HindEH (lane 1 and 14).
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The mutagenesis procedure is outlined in Figure 4.2 and was composed of three main
steps, hi step 1, the cloned gK gene was used to extend the LN5/MUT2 PCR product
Fifty per-cent of the extension reaction products are predicted to contain the
engineered mutation. The size of the first extended product was 2190 bps. The
extended product was used in step 2, with the MUT1 / C3 PCR product this second
extension was predicted to raise the frequency of the mutation to 100%. Final
amplification was performed with primer pair LN5/C3 (Figure 4.2). Final PCR
products were tested for the absence of Bbs I restriction endonuclease site by digestion
with Bbs I (Figure 43).

Markex-rescue and Transfer of the Mutation (Ala 31 to Val 31 change) and
Elimination of the Bbs I Restriction Site from the KOS Genome
Viral DNA from individual plaque purified recombinant viral plaques obtained
from the transfection of full length mutagenized DNA fragments (4279 bps) and
infection with d27-l virus were subjected to PCR using primers P2 and P3 that were
designed to bracket the site of the mutation (Figure 4. 2, A). P2 was located 281 bases
5' to the Bbs I site, and P3 was located 1323 bases 3' to the Bbs I site. Therefore, in
wild-type fragment, digestion by Bbs I of the P2/P3 product is expected to produce
two DNA species of approximately 281 and 1323 bps. The PCR fragments obtained
from purified viral DNAs from the recombinant viral plaques were restricted with Bbs
I. The loss of the Bbs I site was confirmed as both the undigested and digested PCR
fragments were of the same size (1604 bps). (Figure 4.3). Four viral isolates SJVal31
that contained the mutations that change Ala to Val 30 and which do have the Bbs I
restriction endonuclease site were obtained (Figure 4.3 lanes 2 through 9). Control viral
strain HSV-1 (KOS) that has the Bbs I restriction site (Figure 4.3 lane 10 through 13).
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DISCUSSION
An efficient long PCR site-mutagenesis procedure was developed to produce
mutations in the gK gene (Chouljenko et al., 1996). Making use of the strategy to insert
site specific mutations into long DNA fragments in conjunction with the newly
developed recombinant system (discussed in chapter 2), additional mutations were
generated to delineate the 5' boundary of the N-terminal syncytial domain in gK.
The Ala to Val substitution at amino add 31 is a conservative change, in that a
small polar Ala residue was substituted with a larger polar Val residue. A sim ilar
substitution at residue 40 causes extensive cell fusion (Chouljenko et a l, 1996; Dolter et
a l, 1994). The recombinant viruses with the Ala 31 substitution were designated
SJVal31, did not cause extensive cell fusion and the plaque morphology was
indistinguishable from the parental wild-type strain KOS.
MacVector protein analysis software package was utilized to analyze the
predicted primary structure of proteins. The first 50 amino adds specified by the wildtype gK and by the SJVal31 gK are shown in Figure 4.4. These results show the amino
ad d substitution at residue 31 did not result in any drastic changes in the
hydrophilidty, surface probability and secondary structure when compared to the
parental wild-type gK. However, there was a slight reduction in the flexibility and
antigenic index in this region (Figure 4.4). Also, the Ala 31 to Val 31 amino ad d
substitution did not eliminate the existing signal peptidase deavage site.
These results along with the previously published data fine-maps the 5'
boundary of the N-terminal syncytial domain. Ala 31 is the first amino ad d after
deavage of the 30 amino add signal peptide, does not play a role in the viral induced
cell fusion. The amino add residues from 31 thro 36 are not conserved among the other
alphaherpesviruses, however, Ala 31 is part of the first antigenic portion of gK that is
predided to form a (5 turn (Figure 4.4 Secondary Structure).
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Figure 4.4: Secondary Structure Predictions and Com parison of KOS-Ala31 and
SJ-Val31.
Analysis of the engineered amino add in SJ-Val31 compared to the parent KOS-Ala31.
The First 51 amino adds were analyzed using the "Protein Toolbox" application of the
MacVector software package (IBI-Kodak). Hydrophilidty, Antigenic indices,
Flexibility, and secondary structure profiles were compared. CF=Chou-Fasman
secondary structure algorithm; RG= Robson-Gamier secondary structure alogrithm
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Previously, a syncytial m utation HSV-1 (KOS) syn 8 was reported to have a mutation
at Pro 33 and other mutations elsewhere in the gK gene. W hether the Pro 33 to Ser 33
substitution in the absence of other mutations results in a sim ilar cell fusion phenotype
is yet to be determined.
The two other amino a d d substitutions that were engineered by site directed
mutagenesis were Thr 50 to Val 50, and Thr 60 to Val 60 that are conservative amino
add substitutions. The plaque phenotype of the recombinant viruses were similar to
wild-type KOS. PCR analysis showed that the d27-l deletion was repaired, however,
restriction enzyme analysis foiled to detect the engineered restriction endonudease
sites. This indicates that the recombinant viruses did not have the site-specific
substitutions. The obvious explanation for these results is that the deletion in d27-l
virus was rescued by the DNA fragment, however the recombination sites were
probably to the right of the mutations as there is approximately 1 kbps of intervening
sequence between the d27-l deletion and the engineered mutations. Also the low
frequency of recombination with these fragments could point to the fact that the amino
adds substitutions disrupt the N-glycosylation sites in gK that could render this
protein non-functional which would be lethal for viral replication. To further analyze
these mutations, a more stringent recombination system is required. A better virus that
could serve this purpose would be the AgK virus, which has the entire gene coding for
gK deleted. The mutagenized DNA fragments could be used in conjunction with AgK
virus such that the deletion in gK is repaired by the DNA fragments with simultaneous
transfer of the site-specific gK mutations. However, a potential drawback to this
strategy lies in the inability to phenotypically differentiate between the AgK virus
plaques and the recombinant mutant virus plaques which makes the screening process
more labor intensive.
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Glycoprotein K (gK) was hypothesized to be involved in virus induced cell to cell
fusion mechanisms which involves fusion of adjacent cellular membranes resulting in
polykaryotes or syncytia, because a num ber of HSV-1 mutants that cause extensive cell
to cell fusion were mapped to the gK gene. Hutchinson, et al., (1995), constructed a
partially deleted FgK-p virus and dem onstrated that gK is essential for viral replication
and egress, because FgK-P virus could be propagated only on a complementing gKtransformed cell line. In this research, a novel recombination method for transferring
mutations and deletions into the gK gene was developed and a gK-null virus, AgK, w ith
a complete deletion of the gK gene was constructed. In contrast to previous findings
(Hutchinson, et al., 1995), characterization of the phenotypic properties of AgK virus
revealed that gK was dispensable for viral replication in exponentially dividing cells,
however gK was essential for viral replication in stationary phase cells. Furthermore,
gK was required for efficient viral envelopment and in the translocation of infectious
virions from the perinuclear spaces to the cytoplasm and from the cytoplasm to the
extracellular spaces. Based on the findings from this research, a unique role for gK in
the formation and translocation of virion transport vesicles has emerged.
It has been hypothesized that single amino add mutations in gK result in the
syncytial phenotype by decreasing the ability of gK to inhibit cell to cell fusion and in
this regard the gK truncation in FgK-p behaves in a similar manner. Apparently the
hypothesis that gK is an inhibitor of cell to cell fusion is incorrect, because deletion of
the entire gK does not cause cell fusion. It remains unclear how gK partidpates in the
cell fusion phenomenon. Available data indicate that the HSV-induced cell fusion
involves a complex mechanism which involves multiple viral and cellular proteins. It is
worth pointing out that in the carboxy-region of gK, a conserved double Cys motive
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was found, CXXC where X is any amino add, which has sequence similarities to the
mammalian Mss4 protein that is required for vesicular transport Thus it is conceivable
that gK may possess two functional domains where the amino-terminal one-third of
the glycoprotein functions in membrane fusion, probably in the triggering of budding
and /or the formation, of virion transport vesides, whereas the carboxy one-third of
the protein is required for targeting and transport of the vesides. Interestingly, the
presence of unenveloped FgK-(3 capsids in the cytoplasm of infected cells indicate that
the amino-terminal of gK w hen expressed alone causes aberrant fusion of membranes
and probably inhibits the formation and transport of vesides. However, in the total
absence of gK the AgK virions acquires envelopes and are found in the cytoplasm of
actively dividing HEp-2, and Vero cells, indicating that certain cellular factors can
partially compensate for loss of gK function in actively dividing cells. It is tempting to
speculate that gK could mimic or alter the function of certain cellular GTP binding
proteins (such as ARF and SAR) that are involved in the veside budding and
trafficking from the ER to the ds-phase of the Golgi.
Information about the function of gK was also obtained by studying the
replication of wild-type and gK-null viruses in gK-transformed cells. gK-transformed
cell lines are unique in that they restrict the replication of the gK-null viruses and the
plaque production of wild-type viruses, respectively, with the exception of one cell
line. Enveloped wild-type virions were trapped in perinuclear spaces of gKtransformed cells confirming the role of gK in virion translocation and further alluding
to the role of cellular or other viral factors that may interact with the cellular gK and
modulate the formation of virion transport vesides.
Finally, feasibility experiments were performed to fine-map the amino-terminal
syncytial domains in gK by utilizing a long PCR site-directed mutagenesis method.
Three mutations were constructed and one virus recombinant, SJVaBl containing an
Ala to Val substitution at amino add 31 was isolated.
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FUTURE RESEARCH CHALLENGES
Infection of cells by enveloped viruses requires that viruses overcome multiple
membrane barriers. In the case of HSV these barriers include the plasma membrane
during virus entry and the outer nuclear lamella, the Golgi membranes and the plasma
membrane during egress. Also, cells possess complex and well regimented networks by
which proteins and macromolecules that are synthesized within the cell are
transported to the exterior. Viruses with their limited coding capacity have evolved
optimal mechanisms by which they can modulate and overcome these physical barriers
and in turn utilize the cellular environment for both entry, maturation and egress. Thus
there are various viral and cellular proteins that either independently or in synergy
regulate the different membrane fusion events and the translocation of virions.
In particular, these investigations elucidated that gK is involved at various levels
at both virus egress and preliminary evidence shows that it may be involved in viral
entry. This research supports the model that virion particles are transported in
specialized vesicles (modules) as it is thermodynamically unsuitable for viruses to de
envelope and re-envelope multiple times as it transits through the vesicular transport
system. The sequential de-envelope/re-envelopment could compromise the structural
integrity of the virus. It is interesting to note that vesicular glycoprotein transport has
been studied in great depth, however, mechanisms by which large macromolecules
transit through cells are unknown. The vesicles that shuttle proteins between the RER
and the ris-phase of the Golgi have diameters of ~70nm, HSV with a particle size of
-130 nm seems to utilize a sim ilar pathway. A possible mechanism for intracellular
virus transport would be to fuse vesicles together to produce a large transport vesicle.
In this regard, gK with membrane fusing and transport properties can be envisaged to
interact with other cellular or viral factors to modulate and regulate this mechanism.
Future investigations should be aimed at clarifying the role of gK and gKmediated interference in virus entry and to examine the molecular basis of gK's
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involvement in the vesicular transport. Some possible questions and research ideas
proposed in this regard are:
1) To clarify the role of the amino-terminal one-third of gK in fusion by constructing a
KOS mutant virus that is similar to FgK-(3, expressing the amino-terminal one-third of
gK and the 26 amino adds specified by the ICP6 prom oter region. The mutant virus
would express a truncated form of gK in a syngendc background; it would be possible
to determine if the partial fusion phenotype of FgK-p is due to the presence the aminoterminal or if amino-terminal interacts with other HSV-1 specified proteins and
regulates the fusion phenomena.
2) To examine the carboxy-terminal region of gK and identify its role in virion vesicular
transport by either site-directed mutagenesis of the Cys residues in the wild-type KOS
virus or by doning the Mss4 gene into the AgK virus to determine enhanced transport of
viral partides in stationary phase Vero cells.
3) To examine the structural integrity of the AgK virion partide by analyzing the
glycoprotein profile of sucrose gradient purified AgK virions and comparing it with the
purified wild-type KOS virions.
4) To analyze the role of gK in viral attachment and entry and to detect if gK is present
in the virion partide by epitope tagging gK and tracing the intracellular localization of
gK in infected cells.
5) To determine the molecular basis for complementation and interference by different
gK transformed cell lines for both wild-type KOS and AgK viral replication by i)
Obtaining revertant KOS and AgK virions that overcome the viral replication
restrictions in the gK-transformed cells and mapping the genes involved by marker
rescue experiments, ii) Obtain the DNA sequence of the cellular gK gene from the gK
transformed VK302 cells that complement both KOS and AgK virus replication, iii) To
examine the level of constitutive transcription and translation of the cellular gK genes
from different gK transformed cell lines in the absence of viral infection.
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In conclusion this research aimed to improve existing knowledge of HSV-1
glycoprotein K and in particular intracellular infectious virion maturation and egress,
and in this regard, it contributes to the overall understanding of intracellular transport
of viruses and macromolecules not only for herpesviruses but in other enveloped viral
systems. This study along with work from other laboratories would hopefully lead to
advances in understanding of virus-host cell interactions the successful establishment
of infection by viruses and to exploit new targets for antiviral therapy.
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